var title_f37_20_38208="Minoxidil: Patient drug information";
var content_f37_20_38208=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Minoxidil: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block note\" id=\"F12804679\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12804680\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?24/26/24996?source=see_link\">",
"       Minoxidil (systemic): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?32/58/33699?source=see_link\">",
"       Minoxidil (topical): Patient drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11818 Version 27.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.25.216.6-3A7D25EF8E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38208=[""].join("\n");
var outline_f37_20_38208=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?24/26/24996?source=related_link\">",
"      Minoxidil (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?32/58/33699?source=related_link\">",
"      Minoxidil (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_20_38209="Oral lichen planus - erosive";
var content_f37_20_38209=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62826&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62826&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erosive oral lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ulcers are present on the tongue in this patient with erosive oral lichen planus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38209=[""].join("\n");
var outline_f37_20_38209=null;
var title_f37_20_38210="Contents: Upper GI surgery";
var content_f37_20_38210=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?5/48/5902\">",
"       General Surgery",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Upper GI surgery",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Upper GI surgery",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Appendix",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/40/31370\">",
"           Acute appendicitis in adults: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/7/5242\">",
"           Acute appendicitis in adults: Management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/34/42536\">",
"           Acute appendicitis in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/22/31077\">",
"           Appendiceal (ileocecal) mucoceles",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Bariatric surgery",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/52/28489\">",
"           Endoscopy in patients who have undergone bariatric surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/18/27945\">",
"           Fertility and pregnancy after bariatric surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/23/16758\">",
"           Ghrelin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/35/30266\">",
"           Health hazards associated with obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/63/20472\">",
"           Hospital accommodations and staffing for care of the bariatric surgical patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/41/666\">",
"           Imaging after bariatric surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/47/26362\">",
"           Medical management of patients after bariatric surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/45/13016\">",
"           Overview of therapy for obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/50/13094\">",
"           Physiology of leptin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/2/32810\">",
"           Postoperative management of the critically ill obese patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/20/12615\">",
"           Screening for and clinical evaluation of obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/31/33274\">",
"           Surgical management of severe obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/11/29882\">",
"           The impact of obesity on fertility and pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Crohn's disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/7/25722\">",
"           Colorectal cancer surveillance in inflammatory bowel disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/14/25834\">",
"           Fertility, pregnancy, and nursing in inflammatory bowel disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/11/6329\">",
"           Overview of the medical management of severe or refractory Crohn's disease in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/43/25273\">",
"           Perianal complications of Crohn's disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/50/4906\">",
"           Surgical management of ulcerative colitis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Diagnosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/4/27720\">",
"           Approach to the patient with dyspepsia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/30/31205\">",
"           Classification and diagnosis of gastritis and gastropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/30/16874\">",
"           Differential diagnosis of abdominal pain in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/25/32154\">",
"           Transabdominal ultrasonography of the small and large intestine",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastroesophageal reflux disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/8/1161\">",
"           Epidemiology, clinical manifestations, and diagnosis of Barrett's esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/46/9959\">",
"           Helicobacter pylori and gastroesophageal reflux disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/57/42905\">",
"           Surgical management of gastroesophageal reflux in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal bleeding",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/55/28538\">",
"           Approach to acute upper gastrointestinal bleeding in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/39/31352\">",
"           Evaluation of obscure gastrointestinal bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/4/11336\">",
"           Evaluation of occult gastrointestinal bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/23/12664\">",
"           Major causes of upper gastrointestinal bleeding in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/15/24826\">",
"           Overview of the treatment of bleeding peptic ulcers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/60/21446\">",
"           Prediction of variceal hemorrhage in patients with cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/23/17786\">",
"           Prevention of recurrent variceal hemorrhage in patients with cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/49/27418\">",
"           Primary and pre-primary prophylaxis against variceal hemorrhage in patients with cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/61/23514\">",
"           Treatment of active variceal hemorrhage",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal cancer - Appendix",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/60/969\">",
"           Clinical characteristics of carcinoid tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/63/9206\">",
"           Clinical features of the carcinoid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/30/43496\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/32/6665\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/46/39658\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/31/16888\">",
"           Treatment of the carcinoid syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal cancer - Esophagus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/34/33321\">",
"           Adjuvant and neoadjuvant imatinib for gastrointestinal stromal tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/10/44202\">",
"           Chemotherapy for locally advanced unresectable and metastatic esophageal and gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/45/7898\">",
"           Diagnosis and staging of esophageal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/1/42006\">",
"           Endoscopic palliation of esophageal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/13/1242\">",
"           Endoscopic ultrasound for the characterization of subepithelial lesions of the upper gastrointestinal tract",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/35/35386\">",
"           Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/31/32250\">",
"           Epidemiology, pathobiology, and clinical manifestations of esophageal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/7/34938\">",
"           Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/25/30106\">",
"           Management of locally advanced unresectable esophageal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/60/20426\">",
"           Management of superficial esophageal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/30/43496\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/46/39658\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/51/39738\">",
"           Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/12/8391\">",
"           Pathogenesis of Barrett's esophagus and its malignant transformation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/31/39418\">",
"           Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/30/34282\">",
"           Surgical oncologic principles for management of resectable esophageal cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal cancer - Small bowel",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/34/33321\">",
"           Adjuvant and neoadjuvant imatinib for gastrointestinal stromal tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/60/969\">",
"           Clinical characteristics of carcinoid tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/32/8714\">",
"           Clinical presentation and diagnosis of primary gastrointestinal lymphomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/43/10937\">",
"           Diagnosis and staging of small bowel neoplasms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/8/11400\">",
"           Diagnosis of the carcinoid syndrome and tumor localization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/13/1242\">",
"           Endoscopic ultrasound for the characterization of subepithelial lesions of the upper gastrointestinal tract",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/35/35386\">",
"           Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/31/18938\">",
"           Epidemiology, clinical features, and types of small bowel neoplasms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/7/34938\">",
"           Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/53/3930\">",
"           Management of gastrointestinal lymphomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/30/43496\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/32/6665\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/46/39658\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/8/21642\">",
"           Treatment of small bowel neoplasms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/31/16888\">",
"           Treatment of the carcinoid syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal cancer - Stomach",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/34/33321\">",
"           Adjuvant and neoadjuvant imatinib for gastrointestinal stromal tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/38/11882\">",
"           Adjuvant and neoadjuvant treatment of gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/36/2634\">",
"           Association between Helicobacter pylori infection and gastrointestinal malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/60/969\">",
"           Clinical characteristics of carcinoid tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/36/11850\">",
"           Clinical features, diagnosis, and staging of gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/32/8714\">",
"           Clinical presentation and diagnosis of primary gastrointestinal lymphomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/8/11400\">",
"           Diagnosis of the carcinoid syndrome and tumor localization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/10/37033\">",
"           Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/46/4842\">",
"           Early gastric cancer: Treatment, natural history, and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/13/1242\">",
"           Endoscopic ultrasound for the characterization of subepithelial lesions of the upper gastrointestinal tract",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/35/4661\">",
"           Epidemiology of gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/35/35386\">",
"           Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/19/2361\">",
"           Gastric polyps",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/15/2296\">",
"           Hereditary diffuse gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/15/33018\">",
"           Invasive gastric cancer: Surgery and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/56/19333\">",
"           Local palliation for advanced gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/7/34938\">",
"           Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/53/3930\">",
"           Management of gastrointestinal lymphomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/30/43496\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/32/6665\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/46/39658\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/26/33194\">",
"           Pathology and molecular pathogenesis of gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/38/618\">",
"           Risk factors for gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/52/6983\">",
"           Screening and prevention of gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/31/16888\">",
"           Treatment of the carcinoid syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/35/38452\">",
"           Abdominal actinomycosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/33/21015\">",
"           Clostridium difficile and probiotics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/39/29305\">",
"           Clostridium difficile in adults: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/18/36137\">",
"           Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/29/20954\">",
"           Clostridium difficile in adults: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/57/12184\">",
"           Prevention and control of Clostridium difficile in hospital and institutional settings",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/53/29526\">",
"           Pyogenic liver abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/60/3018\">",
"           Tunnel and peritoneal catheter exit site infections in continuous peritoneal dialysis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Helicobacter pylori",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/40/44679\">",
"           Association between Helicobacter pylori infection and duodenal ulcer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/36/2634\">",
"           Association between Helicobacter pylori infection and gastrointestinal malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/10/12455\">",
"           Management of duodenal ulcers in patients infected with Helicobacter pylori",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Inflammatory bowel disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/17/7450\">",
"           Definition, epidemiology, and risk factors in inflammatory bowel disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/14/25834\">",
"           Fertility, pregnancy, and nursing in inflammatory bowel disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/37/22103\">",
"           Glucocorticoid withdrawal",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/31/22006\">",
"           Hepatobiliary manifestations of inflammatory bowel disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/47/27386\">",
"           Major side effects of systemic glucocorticoids",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/50/4906\">",
"           Surgical management of ulcerative colitis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Mesenteric ischemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/21/44377\">",
"           Acute mesenteric ischemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/43/27316\">",
"           Celiac artery compression syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/27/33206\">",
"           Chronic mesenteric ischemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/20/42313\">",
"           Colonic ischemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neuroendocrine tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/57/18330\">",
"           Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/60/969\">",
"           Clinical characteristics of carcinoid tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/63/9206\">",
"           Clinical features of the carcinoid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/8/11400\">",
"           Diagnosis of the carcinoid syndrome and tumor localization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/57/31640\">",
"           Glucagonoma and the glucagonoma syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/34/3623\">",
"           Somatostatinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/59/16311\">",
"           The VIPoma syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/31/16888\">",
"           Treatment of the carcinoid syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Nonesophageal gastrointestinal motility disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/26/2474\">",
"           Chronic intestinal pseudo-obstruction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/53/13142\">",
"           Gastric bezoars",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/62/14312\">",
"           Pathogenesis of delayed gastric emptying",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/50/33576\">",
"           Treatment of delayed gastric emptying",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Non-IBD inflammatory gastrointestinal diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/50/5928\">",
"           Gastrointestinal manifestations of systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/24/24968\">",
"           Gastrointestinal manifestations of vasculitis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Nutrition",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/51/33592\">",
"           Enteral feeding: Gastric versus post-pyloric",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/50/41765\">",
"           Mechanisms of nutrient absorption and malabsorption",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/62/28650\">",
"           Overview of water-soluble vitamins",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/63/20473\">",
"           Percutaneous endoscopic gastrostomy (PEG) tubes: Uses and efficacy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/7/34937\">",
"           Prevention and management of complications from percutaneous endoscopic gastrostomy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Peptic ulcer disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/10/14504\">",
"           Clinical manifestations and diagnosis of Zollinger-Ellison syndrome (gastrinoma)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/18/13609\">",
"           Clinical manifestations of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/21/24919\">",
"           Diagnosis of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/42/19113\">",
"           Epidemiology and etiology of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/23/12664\">",
"           Major causes of upper gastrointestinal bleeding in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/51/6968\">",
"           Management and prognosis of the Zollinger-Ellison syndrome (gastrinoma)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/10/12455\">",
"           Management of duodenal ulcers in patients infected with Helicobacter pylori",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/49/17174\">",
"           Multiple endocrine neoplasia type 1: Definition and genetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/21/40282\">",
"           Overview of the complications of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/18/42281\">",
"           Overview of the natural history and treatment of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/15/24826\">",
"           Overview of the treatment of bleeding peptic ulcers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/61/16345\">",
"           Refractory or recurrent peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/57/33688\">",
"           Role of surgery in the management of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/5/40025\">",
"           Surgical management of complications of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/0/19466\">",
"           Unusual causes of peptic ulcer disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Physiology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/51/35638\">",
"           Physiology of cholecystokinin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/9/25751\">",
"           Physiology of gastrin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/29/4567\">",
"           Physiology of somatostatin and its analogues",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/8/22660\">",
"           Synthesis, secretion, and regulation of gastrointestinal peptides",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Postoperative care",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/47/16120\">",
"           Approach to the adult with nausea and vomiting",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/48/19208\">",
"           Characteristics of antiemetic drugs",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Radiation enteritis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/29/25049\">",
"           Clinical features, diagnosis, and treatment of radiation proctitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/41/13975\">",
"           Diagnosis and management of chronic radiation enteritis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Small bowel obstruction",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/46/14058\">",
"           Small bowel obstruction: Causes and management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/38/8807\">",
"           Small bowel obstruction: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/58/37799\">",
"           Superior mesenteric artery syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Upper GI surgery - Small bowel",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/10/2218\">",
"           Management of patients with a colostomy or ileostomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/25/2458\">",
"           Meckel���������s diverticulum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/33/2586\">",
"           Postoperative ileus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/0/6152\">",
"           Principles of management of enteric fistulas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/46/14058\">",
"           Small bowel obstruction: Causes and management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/38/8807\">",
"           Small bowel obstruction: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Upper GI surgery - Stomach",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/47/44793\">",
"           Gastric outlet obstruction in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/7/7289\">",
"           Gastric volvulus in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/15/2296\">",
"           Hereditary diffuse gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/22/7527\">",
"           Hiatus hernia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/21/40282\">",
"           Overview of the complications of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/34/3625\">",
"           Prophylactic total gastrectomy for hereditary diffuse gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/57/33688\">",
"           Role of surgery in the management of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/5/40025\">",
"           Surgical management of complications of peptic ulcer disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Zollinger-Ellison syndrome",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/10/14504\">",
"           Clinical manifestations and diagnosis of Zollinger-Ellison syndrome (gastrinoma)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/51/6968\">",
"           Management and prognosis of the Zollinger-Ellison syndrome (gastrinoma)",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-B05399FF1A-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f37_20_38210=[""].join("\n");
var outline_f37_20_38210=null;
var title_f37_20_38211="Porokeratosis ptychotropica";
var content_f37_20_38211=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Porokeratosis ptychotropica",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scaly plaques are present in the gluteal fold.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38211=[""].join("\n");
var outline_f37_20_38211=null;
var title_f37_20_38212="Psoriasis legs";
var content_f37_20_38212=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F77308&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F77308&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Plaque psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38212=[""].join("\n");
var outline_f37_20_38212=null;
var title_f37_20_38213="Anemias due to decreased red cell production";
var content_f37_20_38213=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Anemias due to decreased red cell production",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/20/38213/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/20/38213/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/20/38213/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/20/38213/contributors\">",
"     William C Mentzer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/20/38213/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/20/38213/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/20/38213/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of disorders are associated with anemia due to decreased red cell production (ie, hypoproliferative anemia). This situation is simplistically identified by the finding of a low corrected absolute reticulocyte count (reticulocytopenia). Thus, if a normal corrected absolute reticulocyte count is 25,000 to",
"    <span class=\"nowrap\">",
"     75,000/microL",
"    </span>",
"    (1.0 &plusmn; 0.5 percent of the five million red",
"    <span class=\"nowrap\">",
"     cells/microL),",
"    </span>",
"    a corrected absolute reticulocyte count below",
"    <span class=\"nowrap\">",
"     25,000/microL",
"    </span>",
"    indicates poor red cell production. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/46/29418?source=see_link&amp;anchor=H38#H38\">",
"     \"Approach to the adult patient with anemia\", section on 'Reticulocyte count'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are, however, several important caveats to the interpretation of the reticulocyte count:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A reticulocyte count of",
"      <span class=\"nowrap\">",
"       27,000/microL",
"      </span>",
"      (ie, at the lower limit of normal) in an anemic patient does not mean that production is normal for that patient.",
"     </li>",
"     <li>",
"      Suppose a patient is losing blood due to hemolysis or blood loss at a rate five times normal and the reticulocyte increase is only three times normal. In this setting, impaired production is contributing to the anemia even though the corrected absolute reticulocyte count is three times normal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The differential diagnosis of a hypoproliferative anemia can often be narrowed by identification of one of the six specific presenting patterns outlined below. The differential diagnosis of a hypoproliferative anemia with microcytosis, which is most often due to iron deficiency, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/39/26234?source=see_link\">",
"     \"Causes and diagnosis of anemia due to iron deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NORMOCYTIC ANEMIA WITHOUT LEUKOPENIA OR THROMBOCYTOPENIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The peripheral smear in this setting demonstrates normal red blood cell (RBC) morphology. The red cell indices are normal or slightly hypochromic or microcytic. The white blood cell (WBC) count is usually normal although there may be a neutrophilic leukocytosis. The WBC are not dysplastic and blasts are not seen. The platelet count is usually normal or elevated. The platelets are not dysplastic.",
"   </p>",
"   <p>",
"    The bone marrow is usually not examined in these cases. If studied, it would show normal cellularity, normal maturation of the several cell lines, and normal iron stores.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;This pattern can be induced by a number of disorders, each of which is discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Anemia of (chronic) inflammation",
"      </strong>",
"      &mdash; This condition is most often associated with infection, inflammation, or malignancy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/13/9434?source=see_link\">",
"       \"Anemia of chronic disease (anemia of chronic inflammation)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Mild to moderate iron deficiency",
"      </strong>",
"      &mdash; Mild to moderate iron deficiency can be associated with anemia without the classic findings of hypochromia or microcytosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/39/26234?source=see_link\">",
"       \"Causes and diagnosis of anemia due to iron deficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Renal failure",
"      </strong>",
"      &mdash; The anemia associated with renal failure is usually due to a marked reduction in erythropoietin (EPO) production relative to the degree of anemia. The EPO level usually does not fall until the creatinine clearance drops below 30",
"      <span class=\"nowrap\">",
"       mL/minute.",
"      </span>",
"      <br/>",
"      <br/>",
"      Other factors also may contribute in selected patients with renal disease. These include a component of the anemia of chronic inflammation if inflammation is present, a microangiopathic hemolytic anemia when vasculitis is present, or autoimmune hemolysis when a disorder such as systemic lupus erythematosus affects the kidney. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/45/33496?source=see_link\">",
"       \"Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/31/5626?source=see_link\">",
"       \"Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Endocrine disorders",
"      </strong>",
"      &mdash; A mild hypoproliferative anemia can be seen in a number of endocrine disorders, including hypothyroidism, hyperthyroidism, panhypopituitarism, and primary or secondary hyperparathyroidism [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38213/abstract/1\">",
"       1",
"      </a>",
"      ]. How the anemia occurs in these disorders is not well understood, but correction of the endocrine disturbance usually corrects the anemia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     NORMOCYTIC ANEMIA WITH LOW TO ABSENT RETICULOCYTES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presentation in this setting is similar to the above variant with one important exception: the RBC morphology is normal but the reticulocyte count is very low, usually",
"    <span class=\"nowrap\">",
"     &lt;10,000/microL,",
"    </span>",
"    frequently as low as",
"    <span class=\"nowrap\">",
"     2000/microL,",
"    </span>",
"    and occasionally zero.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;This pattern is highly suggestive of pure red cell aplasia. The bone marrow will show normal overall cellularity and morphology except for the virtual absence or marked reduction of all identifiable erythroid precursors. Giant proerythroblasts may be seen in those patients with pure red cell aplasia secondary to infection with parvovirus.",
"   </p>",
"   <p>",
"    There are many causes of acquired pure red cell aplasia in adults, the most common being idiopathic, drug-induced, myelodysplastic syndrome, T cell large granular lymphocyte leukemia, thymoma, and the rheumatologic disorders such as systemic lupus erythematosus. Regardless of the etiology, the final common pathway seems to be an immunologic attack, either mediated by T cells or antibodies to erythropoietin, on erythroid progenitors at a maturity level between CFU-E (colony-forming units-erythroid) and proerythroblasts. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/1/17433?source=see_link\">",
"     \"Acquired pure red cell aplasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/4/8265?source=see_link\">",
"     \"Pure red cell aplasia due to anti-erythropoietin antibodies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/49/14106?source=see_link&amp;anchor=H7#H7\">",
"     \"Hematologic manifestations of systemic lupus erythematosus in adults\", section on 'Red cell aplasia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     NORMOCYTIC ANEMIA WITH PANCYTOPENIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The peripheral smear in these patients usually reveals normal RBC morphology but macrocytosis is occasionally seen. The WBC count is low with prominent neutropenia (absolute neutrophil count below",
"    <span class=\"nowrap\">",
"     1000/microL)",
"    </span>",
"    and, in some cases, lymphopenia",
"    <span class=\"nowrap\">",
"     (&lt;1000/microL)",
"    </span>",
"    as well. WBC morphology is normal. The platelet count is reduced; the platelet morphology is generally normal with occasional large platelets.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoproliferative anemia in the context of pancytopenia without prominent blood cell morphologic abnormalities.",
"   </p>",
"   <p>",
"    Bone marrow examination is almost always performed in patients with pancytopenia, usually in conjunction with cytogenetic studies. The marrow in most cases of hypoproliferative anemia with pancytopenia is either profoundly hypocellular with relatively normal morphology of the remaining elements or hypocellular with dysplasia of red cell, neutrophil, and platelet precursors. In some patients, however, the marrow is totally replaced with malignant cells or fibrosis. Gelatinous degeneration of the marrow with serous fat atrophy has been described in patients with anorexia nervosa. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/62/38890?source=see_link&amp;anchor=H31379427#H31379427\">",
"     \"Anorexia nervosa in adults and adolescents: Medical complications and their management\", section on 'Hematologic'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancytopenia without prominent morphologic abnormalities has a very different set of clinical implications from isolated anemia. The major causes of this problem include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Aplastic anemia",
"     </li>",
"     <li>",
"      Bone marrow suppression following chemotherapy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      radiation therapy",
"     </li>",
"     <li>",
"      Hypoplastic myelodysplastic syndrome",
"     </li>",
"     <li>",
"      Marrow replaced by leukemia, lymphoma, cancer, or rarely, fibrosis",
"     </li>",
"     <li>",
"      Anorexia nervosa and panhypopituitarism [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38213/abstract/2\">",
"       2",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although splenomegaly can also cause pancytopenia (ie, hypersplenism), the increased peripheral destruction seen in hypersplenism is associated with enhanced erythropoiesis and a high reticulocyte count, and the bone marrow is normocellular to hypercellular, rather than aplastic or hypocellular.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MACROCYTIC NONMEGALOBLASTIC ANEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The peripheral smear in this disorder shows RBC that are distinctly macrocytic with very few macroovalocytes (",
"    <a class=\"graphic graphic_picture graphicRef74901 \" href=\"mobipreview.htm?9/45/9942\">",
"     picture 1",
"    </a>",
"    ). The mean cell volume (MCV) is generally greater than 100 fL, but the value depends upon which automated counter is used and how it was standardized. The WBC may be slightly low but there is no dysplasia or blasts. Few, if any, five to six lobed neutrophils are present. The platelet count may be normal or as low as",
"    <span class=\"nowrap\">",
"     50,000/microL.",
"    </span>",
"   </p>",
"   <p>",
"    The",
"    bone marrow is usually not examined in this setting but, if performed, cellularity and maturation are normal. Megaloblastosis, characteristic of cobalamin or folate deficiency, is not seen. Careful examination may reveal vacuoles about the nuclei of proerythroblasts. Special stains may show ringed sideroblasts (",
"    <a class=\"graphic graphic_picture graphicRef65887 \" href=\"mobipreview.htm?0/44/705\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several disorders can produce a hypoproliferative, macrocytic anemia without megaloblastosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/16/21767?source=see_link\">",
"     \"Macrocytosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Alcohol abuse (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/38/4710?source=see_link\">",
"       \"Alcohol abuse and hematologic disorders\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Therapy with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/28/24008?source=see_link\">",
"       zidovudine",
"      </a>",
"      (AZT), other anti-viral agents,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/16/16648?source=see_link\">",
"       hydroxyurea",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      &nbsp;(see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/16/21767?source=see_link\">",
"       \"Macrocytosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Myelodysplastic syndrome, early in its course (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/57/41882?source=see_link\">",
"       \"Clinical manifestations and diagnosis of the myelodysplastic syndromes\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Early in the course of cobalamin or folate deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/32/11786?source=see_link\">",
"       \"Etiology and clinical manifestations of vitamin B12 and folate deficiency\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     MACROCYTIC MEGALOBLASTIC ANEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The peripheral smear in this setting reveals macrocytic RBC with macroovalocytes (",
"    <a class=\"graphic graphic_picture graphicRef74901 \" href=\"mobipreview.htm?9/45/9942\">",
"     picture 1",
"    </a>",
"    ). The WBC count is normal or low, but the neutrophils show hypersegmentation with at least 5 percent of the cells having five or more lobes (",
"    <a class=\"graphic graphic_picture graphicRef70609 \" href=\"mobipreview.htm?12/47/13046\">",
"     picture 3",
"    </a>",
"    ). The platelet count is normal or low.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21996966\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;These findings are highly suggestive of folate or cobalamin (vitamin B12) deficiency. Bone marrow examination is usually not necessary. When performed, it shows hypercellularity with megaloblastic erythroid hyperplasia, contrasting with the reticulocytopenia. Thus, erythropoiesis is profoundly ineffective. The iron stain may show the presence of ringed sideroblasts (",
"    <a class=\"graphic graphic_picture graphicRef65887 \" href=\"mobipreview.htm?0/44/705\">",
"     picture 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/32/11786?source=see_link\">",
"     \"Etiology and clinical manifestations of vitamin B12 and folate deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     LEUKOERYTHROBLASTIC ANEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The peripheral smear in a patient with a leukoerythroblastic anemia shows abnormal RBC morphology with tear-drop forms (dacrocytes) (",
"    <a class=\"graphic graphic_picture graphicRef55274 \" href=\"mobipreview.htm?42/37/43606\">",
"     picture 4",
"    </a>",
"    ), elliptocytes, macrocytes, and circulating nucleated RBC (",
"    <a class=\"graphic graphic_picture graphicRef68110 \" href=\"mobipreview.htm?29/43/30390\">",
"     picture 5",
"    </a>",
"    ). The WBC count may be high, low, or normal, but there is myeloid immaturity extending back to the myeloblast stage. The platelet count is usually low with abnormal morphology, including giant platelets and even megakaryocyte fragments.",
"   </p>",
"   <p>",
"    A leukoerythroblastic picture reflects replacement of the bone marrow by granulomas, cancer (",
"    <a class=\"graphic graphic_picture graphicRef70576 \" href=\"mobipreview.htm?2/11/2228\">",
"     picture 6",
"    </a>",
"    ), fibrosis, or primary myelofibrosis (PMF). The remaining pluripotent stem cells move to the liver and spleen as they did in fetal life, resulting in extramedullary hematopoiesis. The stromal support system in the liver and spleen is not optimal, as it is in the marrow. As a result, hematopoietic cells are released prematurely or abnormally into the circulation. The reticulocyte count is of limited value in this setting because extramedullary hematopoiesis is associated with both disordered release of reticulocytes into the peripheral blood and disordered maturation of nucleated RBC to reticulocytes in the peripheral circulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Having recognized the virtually pathognomonic peripheral smear findings, the differential diagnosis focuses on what is replacing the marrow. Therefore, a bone marrow biopsy (aspiration may result in a dry tap) with appropriate staining (for reticulin and collagen) is necessary. There are two major causes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Metastatic cancer (",
"      <a class=\"graphic graphic_picture graphicRef70576 \" href=\"mobipreview.htm?2/11/2228\">",
"       picture 6",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38213/abstract/3\">",
"       3",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Myelofibrosis, as seen in the myeloproliferative syndromes such as PMF or myelofibrosis associated with acute myeloid leukemia, other cancer, or radiation (",
"      <a class=\"graphic graphic_picture graphicRef57384 \" href=\"mobipreview.htm?17/34/17961\">",
"       picture 7",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/63/1018?source=see_link\">",
"       \"Clinical manifestations and diagnosis of primary myelofibrosis\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21997059\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia due to decreased to absent red blood cell production (ie, hypoproliferative anemia) has been generally defined through a decreased number of circulating reticulocytes (reticulocytopenia). This reduction may be absolute or relative, as follows. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/46/29418?source=see_link&amp;anchor=H38#H38\">",
"     \"Approach to the adult patient with anemia\", section on 'Reticulocyte count'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Absolute reticulocytopenia",
"      </strong>",
"      &mdash; A corrected reticulocyte count",
"      <span class=\"nowrap\">",
"       &lt;25,000/microL",
"      </span>",
"      is abnormal in any clinical setting",
"     </li>",
"     <li>",
"      <strong>",
"       Relative reticulocytopenia",
"      </strong>",
"      &mdash; In an anemic patient, the normal response of the bone marrow is to produce more red cells, resulting in reticulocytosis. If the degree of reticulocyte production is less than the degree of blood loss or the increase in the rate of red cell destruction, anemia will result or will be exaggerated in degree.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21997138\">",
"    <span class=\"h2\">",
"     Patterns of hypoproliferative anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are six general patterns of hypoproliferative anemia, as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Normocytic without leukopenia or thrombocytopenia",
"      </strong>",
"      &mdash; The most common clinical situations with this finding include the anemia of (chronic) inflammation, mild to moderate iron deficiency, renal failure, and endocrine disorders. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Normocytic anemia without leukopenia or thrombocytopenia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Normocytic with severe reticulocytopenia",
"      </strong>",
"      &mdash; This set of findings is most compatible with acquired red cell aplasia. The most common causes include idiopathic, drug-induced, myelodysplastic syndrome, T cell large granular lymphocyte leukemia, and thymoma. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Normocytic anemia with low to absent reticulocytes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Normocytic with pancytopenia",
"      </strong>",
"      &mdash; The most common causes of this setting include aplastic anemia, bone marrow suppression following chemotherapy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      radiation therapy, hypoplastic myelodysplastic syndrome, and marrow replaced by leukemia, lymphoma, cancer, or fibrosis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Normocytic anemia with pancytopenia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Nonmegaloblastic macrocytic anemia",
"      </strong>",
"      &mdash; Clinical conditions exhibiting this picture include alcohol abuse, drug therapy (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/28/24008?source=see_link\">",
"       zidovudine",
"      </a>",
"      (AZT), other anti-viral agents,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/16/16648?source=see_link\">",
"       hydroxyurea",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      ), myelodysplastic syndrome, and early cobalamin or folate deficiency. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Macrocytic nonmegaloblastic anemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Megaloblastic macrocytic anemia",
"      </strong>",
"      &mdash; This pattern is highly suggestive of folate or cobalamin (vitamin B12) deficiency. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Macrocytic megaloblastic anemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Leukoerythroblastic anemia",
"      </strong>",
"      &mdash; The combined presence of tear-drop shaped red cells, nucleated red cells, and early granulocyte precursors in the circulation is called a &ldquo;leukoerythroblastic blood picture.&rdquo; This is most commonly associated with bone marrow involvement with increased fibrosis or the presence of malignant cells. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Leukoerythroblastic anemia'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38213/abstract/1\">",
"      Zingraff J, Dr&uuml;eke T, Marie P, et al. Anemia and secondary hyperparathyroidism. Arch Intern Med 1978; 138:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38213/abstract/2\">",
"      Laway BA, Mir SA, Bhat JR, et al. Hematological response of pancytopenia to glucocorticoids in patients with Sheehan's syndrome. Pituitary 2012; 15:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38213/abstract/3\">",
"      Shamdas GJ, Ahmann FR, Matzner MB, Ritchie JM. Leukoerythroblastic anemia in metastatic prostate cancer. Clinical and prognostic significance in patients with hormone-refractory disease. Cancer 1993; 71:3594.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7147 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-110.170.48.130-F42F8ABDFE-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38213=[""].join("\n");
var outline_f37_20_38213=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21997059\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NORMOCYTIC ANEMIA WITHOUT LEUKOPENIA OR THROMBOCYTOPENIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      NORMOCYTIC ANEMIA WITH LOW TO ABSENT RETICULOCYTES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      NORMOCYTIC ANEMIA WITH PANCYTOPENIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MACROCYTIC NONMEGALOBLASTIC ANEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      MACROCYTIC MEGALOBLASTIC ANEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21996966\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      LEUKOERYTHROBLASTIC ANEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21997059\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21997138\">",
"      Patterns of hypoproliferative anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7147\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7147|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/45/9942\" title=\"picture 1\">",
"      Macroovalocytes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/44/705\" title=\"picture 2\">",
"      Ring sideroblasts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?12/47/13046\" title=\"picture 3\">",
"      Hypersegmented neutrophil",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?42/37/43606\" title=\"picture 4\">",
"      Tear drop cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/43/30390\" title=\"picture 5\">",
"      Leukoerythroblastic blood smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/11/2228\" title=\"picture 6\">",
"      Metastatic cancer marrow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/34/17961\" title=\"picture 7\">",
"      Myelofibrosis bone marrow",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/1/17433?source=related_link\">",
"      Acquired pure red cell aplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/38/4710?source=related_link\">",
"      Alcohol abuse and hematologic disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/13/9434?source=related_link\">",
"      Anemia of chronic disease (anemia of chronic inflammation)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/62/38890?source=related_link\">",
"      Anorexia nervosa in adults and adolescents: Medical complications and their management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/46/29418?source=related_link\">",
"      Approach to the adult patient with anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/39/26234?source=related_link\">",
"      Causes and diagnosis of anemia due to iron deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/63/1018?source=related_link\">",
"      Clinical manifestations and diagnosis of primary myelofibrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/57/41882?source=related_link\">",
"      Clinical manifestations and diagnosis of the myelodysplastic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/45/33496?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/31/5626?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/32/11786?source=related_link\">",
"      Etiology and clinical manifestations of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/49/14106?source=related_link\">",
"      Hematologic manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/16/21767?source=related_link\">",
"      Macrocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/4/8265?source=related_link\">",
"      Pure red cell aplasia due to anti-erythropoietin antibodies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_20_38214="Modafinil: Pediatric drug information";
var content_f37_20_38214=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Modafinil: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?1/8/1159?source=see_link\">",
"    see \"Modafinil: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/26/28069?source=see_link\">",
"    see \"Modafinil: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F197665\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Provigil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F197666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Alertec&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1025755\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Central Nervous System Stimulant",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1025786\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?1/8/1159?source=see_link\">",
"      see \"Modafinil: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children:",
"     <b>",
"      ADHD:",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     Reports of serious dermatologic adverse effects and psychiatric events has resulted in the FDA&rsquo;s Pediatric Advisory Committee unanimously recommending that a specific warning against the use of modafinil in children be added to the manufacturer&rsquo;s labeling; use only if first- and second-line treatments have failed and the benefits outweigh the risks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &lt;30 kg: 200-340* mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &gt;30 kg: 300-425* mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      ADHD:",
"     </b>",
"     100-400 mg once daily (Taylor, 2000);",
"     <b>",
"      Note:",
"     </b>",
"     Randomized, double-blind, placebo-controlled  pediatric studies have utilized an 85 mg film-coated tablet (currently not commercially available) to provide these dosages. All studies utilized a titration method but varied the length of titration (3 weeks vs 7-9 days); clinical improvement was noted earlier in the shorter titration period.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Narcolepsy, obstructive sleep apnea/hypopnea syndrome (OSAHS):",
"     </b>",
"     Adults: Initial: 200 mg as a single daily dose in the morning;",
"     <b>",
"      Note:",
"     </b>",
"     Doses of up to 400 mg/day, given as a single dose, have been well tolerated, but there is no consistent evidence that this dose confers additional benefit.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Shift work sleep disorder (SWSD):",
"     </b>",
"     Adults: Initial: 200 mg as a single dose taken ~1 hour prior to start of work shift;",
"     <b>",
"      Note:",
"     </b>",
"     Doses of up to 400 mg/day, given as a single dose, have been well tolerated, but there is no consistent evidence that this dose confers additional benefit.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"     Safety and efficacy have not been established in severe renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     Severe hepatic impairment: Dose should be reduced to one-half of that recommended for patients with normal liver function.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F197647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 100 mg, 200 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Provigil&reg;: 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Provigil&reg;: 200 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F197632\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F197695\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-IV",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F10961086\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM231722.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM231722.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F5582104\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: May be administer without regard to food, as a single dose in the morning; administer 1 hour prior to the start of work shift in those patients with SWSD",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F5582103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 68&deg;F to 77&deg;F (20&deg;C to 25&deg;C).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1025756\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     To improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy and shift work sleep disorder (SWSD), as adjunctive therapy for obstructive sleep apnea/hypopnea syndrome (OSAHS) (FDA approved in adults);  has also been used for attention-deficit/hyperactivity disorder (ADHD); treatment of fatigue in multiple sclerosis (MS) and other disorders",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F197700\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Chest pain, edema, hypertension, palpitation, tachycardia, vasodilation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, anxiety (dose related), chills, confusion, depression, dizziness, emotional lability, headache (occurs more frequently in adults; dose related), insomnia, nervousness, somnolence, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash (includes some severe cases requiring hospitalization)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain (occurs more frequently in children), anorexia, appetite decreased (occurs more frequently in children), constipation, diarrhea, dyspepsia, flatulence, mouth ulceration, nausea, taste perversion, weight loss (occurs more frequently in children), xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Abnormal urine, hematuria, pyuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Eosinophilia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: LFTs abnormal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain, dyskinesia, hyperkinesia, hypertonia, neck rigidity, paresthesia, tremor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Abnormal vision, amblyopia, eye pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Asthma, epistaxis, lung disorder, pharyngitis, rhinitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis, flu-like syndrome, herpes simplex infection, thirst",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Agranulocytosis, anaphylactic reaction, angioedema, DRESS syndrome, erythema multiforme, hypersensitivity syndrome (multiorgan), mania, psychosis, Stevens-Johnson syndrome, toxic epidermal necrolysis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1025762\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to modafinil, armodafinil, or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F5581403\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with hepatic impairment; dosage reduction is recommended for patients with severe hepatic impairment. Use with caution in patients with pre-existing psychosis or bipolar disorder (may induce mixed/manic episode). May exacerbate symptoms of behavior and thought disorder in psychotic patients; new-onset psychosis or mania may occur with stimulant use; observe for symptoms of aggression, hostility, or suicidal ideation. Use with caution in patients with renal impairment. Use with caution in patients with Tourette syndrome; stimulants may unmask tics. Children may experience a higher frequency of some adverse effects than adults including the following: insomnia (29% vs 5%), decreased appetite (16% vs 4%), weight loss, and abdominal pain. The following were reported in controlled, open label clinical studies in children: Cataplexy increased, hostility, hypnagogic hallucinations, suicidal ideation, and Tourette syndrome.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1025763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Serious and life-threatening rashes, including Stevens-Johnson syndrome and toxic epidermal  necrolysis, have been reported with modafinil. Although initially reported in children during clinical trials, postmarketing cases have occurred in both children and adults. Most cases have occurred within the first 5 weeks of therapy; however, rare cases have occurred after long-term use. No risk factors have been identified to predict occurrence or severity. Patients should be advised to discontinue at first sign of rash. The serious nature of these dermatologic adverse effects, as well reports of psychiatric events, have resulted in the FDA&rsquo;s Pediatric Advisory Committee unanimously recommending that a specific warning against the use of modafinil in children be added to the manufacturer&rsquo;s labeling.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     May impair the ability to engage in potentially hazardous activities. The degree of sleepiness should be reassessed frequently; some patients may not return to a normal level of wakefulness. Produces psychoactive and euphoric effects, alterations of mood, perception, thinking, and feelings typical of other CNS stimulants. No clinical symptoms of withdrawal have been reported; patients should be monitored closely for abuse potential, particularly those with a prior history of drug and/or stimulant abuse.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Rare cases of multiorgan hypersensitivity reactions in association with modafinil use and lone cases of angioedema and anaphylactoid reactions with armodafinil have been reported. Signs and symptoms are diverse, reflecting the involvement of specific organs. Patients typically present with fever and rash associated with organ-system dysfunction. Patients should be advised to report any signs and symptoms related to these effects; discontinuation of therapy is recommended.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     The American Heart Association recommends that all children diagnosed with ADHD who may be candidates for stimulant medication, such as modafinil, should have a thorough cardiovascular assessment prior to initiation of therapy. These recommendations are based upon reports of serious cardiovascular adverse events (including sudden death) in patients (both children and adults) taking usual doses of stimulant medications. Most of these patients were found to have underlying structural heart disease (eg, hypertrophic obstructive cardiomyopathy). This assessment should include a combination of thorough medical history, family history, and physical examination. An ECG is not mandatory but should be considered. Modafinil use is not recommended in patients with a history of angina, cardiac ischemia, recent history of MI, left ventricular hypertrophy, or patients with mitral valve prolapse who have developed mitral valve prolapse syndrome with previous CNS stimulant use. Increase monitoring in patients with hypertension; additional antihypertensive therapy may be necessary.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Effectiveness of steroidal contraceptives may be reduced when administered concomitantly with modafinil; alternative or concomitant methods of contraception are recommended for patients receiving modafinil and for 1 month following discontinuation. Cyclosporine serum concentrations may be reduced with modafinil use; monitor cyclosporine concentrations.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F197688\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2A6 (weak), CYP2C19 (strong), CYP2C9 (weak), CYP2E1 (weak), CYP3A4 (weak);",
"     <b>",
"      Induces",
"     </b>",
"     CYP1A2 (weak/moderate), CYP2B6 (weak/moderate), CYP3A4 (weak/moderate)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F197641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inducers may decrease the serum concentration of ARIPiprazole.  Management: Double the oral aripiprazole dose and closely monitor clinical response.  Reduce the oral aripiprazole dose to 10-15 mg/day if the inducer is discontinued. Avoid use of CYP3A4 inducers for more than 14 days with extended-release injectable aripiprazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Axitinib: CYP3A4 Inducers (Weakly to Moderately Effective) may decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: Modafinil may decrease the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: May enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Citalopram: CYP2C19 Inhibitors (Strong) may increase the serum concentration of Citalopram.  Management: Limit citalopram dose to a maximum of 20 mg/day if used with a strong CYP2C19 inhibitor.  Patients using this combination should be monitored closely for evidence of citalopram toxicity (e.g., serotonin syndrome, QT prolongation, etc.).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Clopidogrel: CYP2C19 Inhibitors (Strong) may decrease serum concentrations of the active metabolite(s) of Clopidogrel.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Estrogens): Modafinil may decrease the serum concentration of Contraceptives (Estrogens).  Management: The manufacturer recommends that patients use nonhormonal contraceptives, in addition to or in place of hormonal contraceptives, during and for one month following treatment with modafinil.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Modafinil may decrease the serum concentration of CycloSPORINE (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Substrates: CYP2C19 Inhibitors (Strong) may decrease the metabolism of CYP2C19 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Linezolid: May enhance the hypertensive effect of Sympathomimetics. Management: Reduce initial doses of sympathomimetic agents, and closely monitor for enhanced pressor response, in patients receiving linezolid.  Specific dose adjustment recommendations are not presently available.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inducers may decrease the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1025776\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Delays absorption (by &sim;1 hour), but does not affect bioavailability.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F197642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F197654\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Embryotoxic effects have been observed in some, but not all animal studies. There are no adequate and well-controlled studies in pregnant women; use only when the potential risk of drug therapy is outweighed by the drug's benefits.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;\">",
"     Healthcare providers are encouraged to register pregnant patients exposed to modafinil by calling 1-866-404-4106.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;\">",
"     Efficacy of steroidal contraceptives (including depot and implantable contraceptives) may be decreased; alternate means of contraception should be considered during therapy and for 1 month after modafinil is discontinued.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1025792\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor CNS activity, blood pressure (if hypertensive patient), heart rate, appetite",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1025777\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The exact mechanism of action is unclear. It does not appear to alter the release of dopamine or norepinephrine and it may exert its stimulant effects by decreasing GABA-mediated neurotransmission, although this theory has not yet been fully evaluated. Several studies also suggest that an intact central alpha-adrenergic system is required for modafinil's activity; the drug increases high-frequency alpha waves while decreasing both delta and theta wave activity, and these effects are consistent with generalized increases in mental alertness.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1025779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Modafinil is a racemic compound (at steady state total exposure to the",
"     <i>",
"      l",
"     </i>",
"     -isomer is ~3 times that for the",
"     <i>",
"      d",
"     </i>",
"     -isomer) whose enantiomers have different pharmacokinetics and do not interconvert.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 0.9 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: ~60%, primarily to albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic; multiple pathways including CYP3A4",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: Effective half-life: 15 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urine (as metabolites; &lt;10% as unchanged drug)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1025795\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/26/28069?source=see_link\">",
"      see \"Modafinil: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Take exactly as prescribed; do not exceed recommended dosage without consulting healthcare provider. Avoid alcohol; may cause drowsiness and impair ability to perform activities requiring mental alertness or physical coordination; may cause dry mouth. At first signs of a rash, immediately discontinue therapy and contact a healthcare provider.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Amiri S, Mohammadi MR, Mohammadi M, et al, &ldquo;Modafinil as a Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Double-Blind, Randomized Clinical Trial,\"",
"      <i>",
"       Prog Neuropsychopharmacol Biol Psychiatry",
"      </i>",
"      , 2007, August 8 [Epub ahead of print].",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/17765380/pubmed\" id=\"17765380\" target=\"_blank\">",
"        17765380",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Biederman J and Pliszka SR, \"Modafinil Improves Symptoms of Attention-Deficit/Hyperactivity Disorder Across Subtypes in Children and Adolescents,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2008, 152(3):394-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/18280848/pubmed\" id=\"18280848\" target=\"_blank\">",
"        18280848",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Biederman J, Swanson JM, Wigal SB, et al, &ldquo;Efficacy and Safety of Modafinil Film-Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2005, 116(6):e777-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/16322134/pubmed\" id=\"16322134\" target=\"_blank\">",
"        16322134",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Broughton RJ, Fleming JA, George, CF, et al, &ldquo;Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Modafinil in the Treatment of Excessive Daytime Sleepiness in Narcolepsy,&rdquo;",
"      <i>",
"       Neurology",
"      </i>",
"      , 1997, 49(2):444-51.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/9270575/pubmed\" id=\"9270575\" target=\"_blank\">",
"        9270575",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Greenhill LL, Biederman J, Boellner SW, etal, &ldquo;A Randomized, Double-Blind, Placebo-Controlled Study of Modafinil Film-Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder,&rdquo;",
"      <i>",
"       J AM Acad Child Adolesc Psychiatry",
"      </i>",
"      , 2006, 45(5):503-11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/16601402/pubmed\" id=\"16601402\" target=\"_blank\">",
"        16601402",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Grozinger M, &ldquo;Interaction of Modafinil and Clomipramine as Comedication in a Narcoleptic Patient,&rdquo;",
"      <i>",
"       Clin Neuropharmacol",
"      </i>",
"      , 1998, 21(2):127-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/9579300/pubmed\" id=\"9579300\" target=\"_blank\">",
"        9579300",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kumar R, \"Approved and Investigational Uses of Modafinil: An Evidence-Based Review,\"",
"      <i>",
"       Drugs",
"      </i>",
"      , 2008, 68(13):1803-39.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/18729534/pubmed\" id=\"18729534\" target=\"_blank\">",
"        18729534",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rugino TA and Copley TC, &ldquo;Effects of Modafinil in Children With Attention-Deficit/Hyperactivity Disorder: An Open-Label Study,&rdquo;",
"      <i>",
"       J Am Acad Child Adolesc Psychiatry",
"      </i>",
"      , 2001, 40(2):230-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/11211372/pubmed\" id=\"11211372\" target=\"_blank\">",
"        11211372",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schwartz JR, \"Modafinil in the Treatment of Excessive Sleepiness,\"",
"      <i>",
"       Drug Des Devel Ther",
"      </i>",
"      , 2009, 2:71-85.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/19920895/pubmed\" id=\"19920895\" target=\"_blank\">",
"        19920895",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Swanson JM, Greenhill LL, Lopez FA, et al, &ldquo;Modafinil Film-Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study Followed by Abrupt Discontinuation,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 2006, 67(1):137-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/16426100/pubmed\" id=\"16426100\" target=\"_blank\">",
"        16426100",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Taylor FB and Russo J, \"Efficacy of Modafinil Compared to Dextroamphetamine for the Treatment of Attention Deficit Hyperactivity Disorder in Adults,\"",
"      <i>",
"       J Child Adolesc Psychopharmacol",
"      </i>",
"      , 2000, 10(4):311-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/11191692/pubmed\" id=\"11191692\" target=\"_blank\">",
"        11191692",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      U.S. Modafinil in Narcolepsy Multicenter Study Group, &ldquo;Randomized Trial of Modafinil for the Treatment of Pathological Somnolence in Narcolepsy,&rdquo;",
"      <i>",
"       Ann Neurol",
"      </i>",
"      , 1998, 43(1):88-97.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/9450772/pubmed\" id=\"9450772\" target=\"_blank\">",
"        9450772",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vetter VL, Elia J, Erickson C, et al, \"Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Medications for Attention Deficit/Hyperactivity Disorder [Corrected]: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2008, 117(18):2407-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/18427125/pubmed\" id=\"18427125\" target=\"_blank\">",
"        18427125",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wigal SB, Biederman J, Swanson JM, et al, &ldquo;Efficacy and Safety of Modafinil Film-Coated Tablets in Children and Adolescents With or Without Prior Stimulant Treatment for Attention-Deficit/Hyperactivity Disorder: Pooled Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Studies,&rdquo;",
"      <i>",
"       Prim Care Companion J Clin Psychiatry",
"      </i>",
"      , 2006, 8(6):352-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/20/38214/abstract-text/17245457/pubmed\" id=\"17245457\" target=\"_blank\">",
"        17245457",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13066 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-CDD449C725-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38214=[""].join("\n");
var outline_f37_20_38214=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F197665\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F197666\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1025755\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1025786\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F197647\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F197632\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F197695\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10961086\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5582104\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5582103\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1025756\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F197700\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1025762\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5581403\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1025763\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F197688\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F197641\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1025776\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F197642\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F197654\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1025792\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1025777\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1025779\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1025795\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13066\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13066|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?1/8/1159?source=related_link\">",
"      Modafinil: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/26/28069?source=related_link\">",
"      Modafinil: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_20_38215="Tissue Doppler echo with velocity and strain plots";
var content_f37_20_38215=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F83923&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F83923&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 476px\">",
"   <div class=\"ttl\">",
"    Tissue Doppler echocardiographic image with longitudinal velocity, strain rate, and strain curves",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 456px; height: 622px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An echocardiographic apical four chamber&nbsp;tissue Doppler image of a normal subject (left panel). The yellow line represents an ultrasound scan line with velocities from two points (V1 and V2) separated by length (L) used to determine strain rate. The right panels show a representative longitudinal velocity curve (top), a strain rate curve (middle), and a strain curve (bottom) from the same cardiac cycle in this individual.",
"    <div class=\"footnotes\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38215=[""].join("\n");
var outline_f37_20_38215=null;
var title_f37_20_38216="Multifocal atrial tachycardia";
var content_f37_20_38216=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Multifocal atrial tachycardia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/20/38216/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/20/38216/contributors\">",
"     Alfred Buxton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/20/38216/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/20/38216/contributors\">",
"     Leonard I Ganz, MD, FHRS, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/20/38216/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/20/38216/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/20/38216/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multifocal atrial tachycardia (MAT) is an arrhythmia that can be seen in a variety of clinical disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition to a heart rate greater than 100 beats per minute, the characteristic electrocardiographic feature is variability in P wave morphology, with each unique P wave morphology felt to indicate a different site of atrial origin. Although this abnormality had been noted for many years during some types of atrial tachycardia, the term MAT became commonplace terminology in the late 1960s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/2\">",
"     2",
"    </a>",
"    ]. Patients with multiple P wave morphologies but a normal heart rate (60 to 100 beats per minute) are considered to have a wandering atrial pacemaker, since the heart rate does not meet criteria for a tachycardia. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Terminology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    This topic will review the definition, pathogenesis, etiology, and treatment of MAT in adults. Other tachycardias of atrial origin, as well as the discussion of this arrhythmia in children, are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/22/21864?source=see_link\">",
"     \"Focal atrial tachycardia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/34/16937?source=see_link\">",
"     \"Atrial tachycardias in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24793?source=see_link\">",
"     \"Atrioventricular nodal reentrant tachycardia (junctional reciprocating tachycardia)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/47/24311?source=see_link\">",
"     \"Atrioventricular reentrant tachycardia (AVRT) associated with an accessory pathway\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/22/361?source=see_link\">",
"     \"Overview of atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION, PATHOGENESIS, AND PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with any tachycardia, the heart rate in MAT exceeds 100 beats per minute. To distinguish MAT from other tachyarrhythmias of atrial origin, there should be organized atrial activity yielding P waves with three or more different morphologies. (See",
"    <a class=\"local\" href=\"#H23844503\">",
"     'Clinical manifestations and diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Terminology",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of authors have used the term \"chaotic\" to describe MAT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. However, chaos in modern usage in nonlinear dynamics and mathematics implies there is order in what appear to be random events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/6\">",
"     6",
"    </a>",
"    ]. A more accurate term for this arrhythmia is probably \"multiform\" as there is no proof that the arrhythmia is actually multifocal, although multifocal remains the commonly used term [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The tachycardic threshold for multifocal atrial tachycardia (MAT) has traditionally been set at 100 bpm, but a review of 60 patients with multifocal atrial arrhythmias found a stronger association between the incidence of COPD exacerbations and the diagnosis of MAT if a threshold of 90 bpm was used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some patients have similar electrocardiographic (ECG) findings with multiple P wave morphologies but do not meet criteria for tachycardia. The arrhythmia is called a multifocal atrial rhythm or wandering atrial pacemaker if the rate is between 60 and 100 beats per minute. A distinction has been made between the two based on the clinical picture, with a wandering atrial pacemaker usually occurring in the asymptomatic or less ill individual [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The changing morphology of the P waves and the variable PR interval suggests that the atrial pacemaker activity arises from different atrial locations. However, the variable PR interval is probably more likely a result of the variable atrial rate. Alternatively, a single focus with different exit pathways or abnormalities in intraatrial conduction could produce the identical electrocardiographic findings. There have only been a few invasive electrophysiologic investigations of MAT, but one study did show abnormal intraatrial, atrionodal, and atrioventricular nodal conduction in many individuals with MAT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Automaticity refers to normal, accelerated normal, or abnormal pacemaker activity. Triggered activity, on the other hand, results from a normal stimulus giving rise to afterpotentials, which, if threshold is attained, can result in regenerative action potentials in any cardiac tissue. Reentry refers to a circuit in which previously excited tissue is re-excited, producing an extra beat or a sustained rhythm. The occasional responsiveness of MAT to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    suggests intracellular calcium overload causing afterdepolarizations leading to triggered activity as the underlying mechanism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is thought that MAT results from right atrial hypertension and distension, either from secondary pulmonary hypertension from advanced COPD or left ventricular dysfunction caused by comorbid processes such as coronary heart disease, systemic hypertension, or aortic stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. However, although frequently associated with exacerbations of pulmonary disease, MAT may occur in other circumstances, so atrial distension may not be a universal mechanism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Associated arrhythmias",
"    </span>",
"    &nbsp;&mdash;&nbsp;MAT (and wandering atrial pacemaker) is commonly accompanied by atrial premature beats and can itself be considered a prolonged sequence of atrial premature beats [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1\">",
"     1",
"    </a>",
"    ]. The majority of episodes of MAT are self-limited and non-sustained.",
"   </p>",
"   <p>",
"    MAT may be associated with or precede atrial fibrillation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/2,12\">",
"     2,12",
"    </a>",
"    ]. In one report of 31 patients, for example, 55 percent developed atrial fibrillation or flutter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;MAT is an uncommon but not rare arrhythmia. It has been estimated to occur in 0.05 to 0.32 percent of electrocardiograms in general hospitals and in 0.37 percent of hospitalized patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The average age is approximately 70 years. These elderly patients are generally quite ill, with an in-hospital mortality rate of 40 to 60 percent due to pulmonary, cardiac, and other serious diseases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23843900\">",
"    <span class=\"h1\">",
"     ASSOCIATED CLINICAL CONDITIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pulmonary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;MAT is associated with significant lung disease in roughly 60 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1\">",
"     1",
"    </a>",
"    ]. Furthermore, this arrhythmia has been identified in up to 20 percent of patients hospitalized for acute respiratory failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/14\">",
"     14",
"    </a>",
"    ]. COPD is the most common pulmonary disorder associated with MAT, but this arrhythmia can also occur with pneumonia and pulmonary embolism. Hypoxia, hypercapnia, acidosis, autonomic imbalance, right atrial enlargement, and therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/19/14648?source=see_link\">",
"     aminophylline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/31/23029?source=see_link\">",
"     isoproterenol",
"    </a>",
"    all may contribute to the enhanced ectopic atrial activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/2,8,15\">",
"     2,8,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/21/8538?source=see_link\">",
"     \"Arrhythmias in COPD\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Cardiac disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;MAT can occur in the presence of coronary, valvular, hypertensive and other types of heart disease, particularly when associated with heart failure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    underlying lung disease. Affected patients tend to have elevated pulmonary capillary wedge and pulmonary end-diastolic pressures as well as a low-normal cardiac index [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/16\">",
"     16",
"    </a>",
"    ]. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/2,12\">",
"     2,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Interactions between cardiac and pulmonary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In advanced cases of cardiac and pulmonary disease, MAT may be part of a complicated pathophysiologic complex in which several conditions (eg, pulmonary hypertension, elevated left ventricular filling pressures, and MAT) contribute to the progression and persistence of each other [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/11,17,18\">",
"     11,17,18",
"    </a>",
"    ]. Illustrations of these relationships include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Severe pulmonary arterial hypertension has been associated with and may cause LV diastolic dysfunction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/17,18\">",
"       17,18",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/47/19193?source=see_link\">",
"       \"Overview of pulmonary hypertension in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/22/43368?source=see_link\">",
"       \"Clinical manifestations and diagnosis of diastolic heart failure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Theoretically, the rapid heart rate associated with MAT decreases diastolic filling time and can result in increased LV diastolic pressure, which in turn increases pulmonary artery pressure that encourages MAT [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/11\">",
"       11",
"      </a>",
"      ]. However, the vast majority of episodes of MAT are brief and not associated with symptoms. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/22/43368?source=see_link\">",
"       \"Clinical manifestations and diagnosis of diastolic heart failure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Prolonged episodes of a rapid heartbeat can cause a cardiomyopathy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27097?source=see_link\">",
"       \"Tachycardia-mediated cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Miscellaneous",
"    </span>",
"    &nbsp;&mdash;&nbsp;MAT is also associated with a number of other disorders:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypokalemia &ndash; MAT has been associated with hypokalemia, most often induced by diuretic use [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1-3\">",
"       1-3",
"      </a>",
"      ]. Hypokalemia may predispose to MAT by increasing the rate of phase 4 depolarization (",
"      <a class=\"graphic graphic_figure graphicRef64133 \" href=\"mobipreview.htm?26/24/27023\">",
"       figure 1",
"      </a>",
"      ) in atrial tissues. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/2/9258?source=see_link&amp;anchor=H3819903#H3819903\">",
"       \"Clinical manifestations and treatment of hypokalemia\", section on 'Cardiac arrhythmias and ECG abnormalities'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypomagnesemia &ndash; The administration of magnesium can suppress MAT in hypomagnesemic and, at times, in apparently normomagnesemic patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/19\">",
"       19",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/37/42580?source=see_link\">",
"       \"Signs and symptoms of magnesium depletion\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Drugs &ndash; As noted above,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?22/31/23029?source=see_link\">",
"       isoproterenol",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?14/19/14648?source=see_link\">",
"       aminophylline",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/31/30200?source=see_link\">",
"       theophylline",
"      </a>",
"      can induce or exacerbate MAT, particularly in the presence of pulmonary disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/2,8,15\">",
"       2,8,15",
"      </a>",
"      ]. In comparison, digitalis is generally not considered to be a cause of MAT, although some reports suggest that such an association may exist [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/2,3,12,13,20,21\">",
"       2,3,12,13,20,21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chronic renal failure &ndash; Approximately 15 percent of patients with MAT have chronic renal failure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/3,20\">",
"       3,20",
"      </a>",
"      ]. It is unclear, however, if this represents a cause-and-effect relationship.",
"     </li>",
"     <li>",
"      Other &ndash; MAT also can occur in sepsis and after recent surgery, particularly if the patient has pulmonary compromise",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      heart failure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1,2\">",
"       1,2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     MAT in children and young adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association of MAT with serious illness is generally less in children than in adults. Information on multifocal (or chaotic) atrial tachycardia in children is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/34/16937?source=see_link&amp;anchor=H5913182#H5913182\">",
"     \"Atrial tachycardias in children\", section on 'Chaotic atrial tachycardia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23844503\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases, the clinical manifestations of MAT differ from those of other tachyarrhythmias in that symptoms predominantly relate to the underlying precipitating illness rather than the arrhythmia. Patients have an irregular heart rate greater than 100 beats per minute. The arrhythmia is usually recognized only by ECG monitoring, as the majority of patients are acutely ill and on continuous ECG monitoring. Patients rarely present with symptoms such as palpitations. Presyncope or syncope is generally not associated with this arrhythmia. Given that the majority of patients with MAT are concurrently affected by advanced or decompensated pulmonary disease, many patients have typical symptoms related to the underlying lung disease (eg, shortness of breath, wheezing, productive cough, etc) or acute metabolic derangements.",
"   </p>",
"   <p>",
"    Most episodes of MAT do not precipitate hemodynamic compromise or limiting symptoms. However, higher heart rates associated with MAT can sometimes worsen systemic oxygenation in patients with advanced pulmonary disease. Additionally, in patients with coexistent advanced cardiac disease, namely those with severe multivessel obstructive coronary artery disease or decompensated heart failure, the faster heart rates associated with MAT can exacerbate heart disease, leading to signs and symptoms of cardiac decompensation (eg, angina, dyspnea, orthopnea). Symptomatic decompensation of underlying cardiac or pulmonary disease is an indication for pharmacologic therapy aimed specifically at the tachycardia rather than therapy to control the underlying disease process. (See",
"    <a class=\"local\" href=\"#H754574\">",
"     'Pharmacologic therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The diagnosis of MAT can be suspected from the presence of an irregular rapid pulse and heartbeat on physical examination, usually in a patient with underlying, often poorly controlled, cardiac or pulmonary disease. The diagnosis cannot be confirmed, however, without an electrocardiogram (ECG).",
"   </p>",
"   <p>",
"    A diagnosis of MAT requires the following be present on the ECG (",
"    <a class=\"graphic graphic_waveform graphicRef70173 \" href=\"mobipreview.htm?13/22/13671\">",
"     waveform 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Discrete P waves with at least",
"      <strong>",
"       three",
"      </strong>",
"      different morphologies (including the normal sinus P wave).",
"     </li>",
"     <li>",
"      An atrial rate greater than 100 beats per minute, which is the classic definition of MAT [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/2\">",
"       2",
"      </a>",
"      ]. However, based upon data from a series of patients with chronic obstructive pulmonary disease (COPD), a threshold of 90 bpm has been proposed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      P waves which return to the baseline and thus are separated by isoelectric intervals.",
"     </li>",
"     <li>",
"      P-P intervals, P-R duration, and R-R intervals which vary.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1117337\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis for MAT is similar to that of other narrow QRS complex tachycardias with an irregular rhythm (assuming there is normal AV conduction without bundle branch block) and includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sinus tachycardia with frequent atrial premature beats (APBs) or ventricular premature beats (VPBs)",
"     </li>",
"     <li>",
"      Atrial flutter with variable AV conduction",
"     </li>",
"     <li>",
"      Atrial fibrillation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    MAT can usually be differentiated from both atrial flutter with variable AV conduction and sinus tachycardia with",
"    <span class=\"nowrap\">",
"     APBs/VPBs",
"    </span>",
"    by the regular P-P interval seen in both atrial flutter and sinus tachycardia, which is not present in MAT. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/56/12165?source=see_link&amp;anchor=H2#H2\">",
"     \"Electrocardiographic and electrophysiologic features of type II atrial flutter\", section on 'Electrocardiogram'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MAT, with its organized atrial activity resulting in P waves on surface ECG, can be readily distinguished from atrial fibrillation, which lacks any discernible P waves. However, MAT can and does degenerate into atrial fibrillation in some patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/42/26278?source=see_link\">",
"     \"The electrocardiogram in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A more in-depth discussion of the differential diagnosis of narrow QRS complex tachycardias is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/35/39481?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations, diagnosis, and evaluation of narrow QRS complex tachycardias\", section on 'Types of narrow QRS complex tachycardia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H754560\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most episodes of MAT do not precipitate hemodynamic compromise or limiting symptoms. Thus, therapy in patients with MAT should be aimed at the inciting underlying disease. Amelioration of MAT generally parallels improvement in severe pulmonary or cardiac disease or sepsis. Not infrequently, medication used for the treatment of pulmonary disease, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    , induces or exacerbates MAT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/2,8,15\">",
"     2,8,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to treatment for the underlying pathologic condition associated with MAT, specific therapies for the tachycardia are sometimes used. In patients with electrolyte disturbances, maintaining magnesium and potassium levels in the normal range is important. Pharmacologic therapy to slow the ventricular heart rate, using either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    or a beta blocker, is administered for patients with signs or symptoms felt to be related to their tachycardia. While rate control therapy is often very effective, there is no role for electrical cardioversion or antiarrhythmic drug therapy in patients with MAT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H754567\">",
"    <span class=\"h2\">",
"     Magnesium and potassium repletion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with MAT and associated hypokalemia or hypomagnesemia should undergo electrolyte repletion prior to the initiation of additional medical therapy for MAT.",
"   </p>",
"   <p>",
"    Hypomagnesemia appears to promote the development of some atrial and ventricular arrhythmias. The administration of magnesium has been reported to suppress MAT in the hypomagnesemic patient and, at times, in patients with normal plasma magnesium levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/19,22\">",
"     19,22",
"    </a>",
"    ]. As an example, one study randomized 14 patients with chronic obstructive pulmonary disease and MAT to magnesium therapy (2 grams over 5 minutes and 10 grams over 5 hours) or placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/22\">",
"     22",
"    </a>",
"    ]. At 5 hours, patients treated with magnesium had a slowing of heart rate from 130 to 99 beats per minute, while there was no change in the placebo group. Sinus rhythm was present at the end of the infusion in 7 of 9 patients treated with magnesium versus one of five receiving placebo. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/37/42580?source=see_link\">",
"     \"Signs and symptoms of magnesium depletion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mild hypomagnesemia (serum magnesium &lt;1.7",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    can be treated with 240 mg of elemental magnesium orally twice per day as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/32/28165?source=see_link\">",
"     magnesium oxide",
"    </a>",
"    (400 mg twice daily) or a delayed release",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/22/24933?source=see_link\">",
"     magnesium chloride",
"    </a>",
"    preparation. Dose-dependent diarrhea occurs frequently. More significant hypomagnesemia (serum magnesium &lt;1.4",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    can be treated with 1 gram (8 mEq) of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    given intravenously over 15 minutes, followed by a continuous infusion of 3 to 6 grams (24 to 48 mEq) over 24 hours, OR as repeated intermittent infusions, each consisting of 1 gram over 1 hour, for a total of 3 to 6 grams over 12 hours. Because magnesium distributes gradually to tissues, early serum levels can appear artificially high, and repletion may require several days of treatment. The dose should be reduced by approximately 50 percent with even mild renal insufficiency. The initial dose may give an indication of whether the MAT will be responsive to magnesium therapy. (Conversion relationships: 1 mmol = 2 mEq = 24 mg of elemental magnesium.)",
"   </p>",
"   <p>",
"    Potassium repletion in the hypokalemic patient may also control MAT, with or without magnesium supplementation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/19,23\">",
"     19,23",
"    </a>",
"    ]. In an observational study of eight patients, the combined use of magnesium and potassium was associated with conversion to sinus rhythm in seven [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Potassium depletion can be treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/57/34711?source=see_link\">",
"     potassium chloride",
"    </a>",
"    given either orally (20 to 60 mEq per day in divided doses if &gt;40 mEq) or intravenously (generally up to 10 mEq per hour, but occasionally at an initial rate of as much as 40 mEq per hour with severe hypokalemia with continuous ECG monitoring). The patient's serum potassium should be carefully monitored to avoid hyperkalemia. Over the long-term, the cause of potassium loss should also be treated, (eg, the administration of a potassium-sparing diuretic to patients treated with loop or thiazide diuretics). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/2/9258?source=see_link\">",
"     \"Clinical manifestations and treatment of hypokalemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H754574\">",
"    <span class=\"h2\">",
"     Pharmacologic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of antiarrhythmic drugs in the treatment of MAT has generally been disappointing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1\">",
"     1",
"    </a>",
"    ]. There is, however, evidence of benefit with agents to control the ventricular heart rate, namely",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    and beta blockers.",
"   </p>",
"   <p>",
"    Medical therapy for MAT is indicated only if MAT causes a sustained rapid ventricular response that causes or worsens myocardial ischemia, heart failure, peripheral perfusion, or oxygenation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/24\">",
"     24",
"    </a>",
"    ]. For patients with symptomatic MAT requiring ventricular rate control, we recommend therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    or a beta blocker (",
"    <a class=\"graphic graphic_table graphicRef83358 \" href=\"mobipreview.htm?10/28/10700\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H754581\">",
"    <span class=\"h3\">",
"     Non-dihydropyridine calcium channel blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;While both",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/16/12554?source=see_link\">",
"     diltiazem",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    can be effective agents for slowing atrioventricular (AV) nodal conduction and controlling ventricular heart rates, verapamil has been most commonly used in MAT, and the response in some cases suggests that triggered activity may initiate the arrhythmia. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Mechanisms'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"     Verapamil",
"    </a>",
"    decreases the ventricular rate by reducing the degree of atrial ectopy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    by limiting the transmission of beats through the AV node [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1,16,25-27\">",
"     1,16,25-27",
"    </a>",
"    ]. In an analysis of pooled data, verapamil lowered the ventricular rate by an average of 31 beats per minute, but only 43 percent of patients reverted to a sinus rhythm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1\">",
"     1",
"    </a>",
"    ]. Furthermore, MAT may recur if verapamil is discontinued.",
"   </p>",
"   <p>",
"    The following regimen, given with continuous ECG and blood pressure monitoring, has been suggested for intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    (",
"    <a class=\"graphic graphic_table graphicRef83358 \" href=\"mobipreview.htm?10/28/10700\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/9\">",
"     9",
"    </a>",
"    ]. A 1 mg test dose is given. The onset of action is within 1 to 2 minutes, with a peak effect at 10 to 15 minutes. If, after 2 minutes, the dose is tolerated, an additional 4 mg is administered over 5 minutes. If MAT persists and high-degree AV block is not present, an additional 5 mg is given over 5 minutes. Ten mg is typically sufficient, but if the response to the initial doses is inadequate and if verapamil has been well tolerated, one to two additional 5 mg doses over 5 minutes at 10-minute intervals can be administered if needed. If MAT reverts to sinus rhythm, oral verapamil is given at an initial dose of 80 mg every 6 hours and subsequently titrated as blood pressure and heart rate allow (total daily dose range 120 to 480 mg).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H754588\">",
"    <span class=\"h3\">",
"     Beta blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beta blockers can suppress ectopic foci and decrease transmission through the AV node, thereby slowing the ventricular response. Their use in MAT has been limited because of the risk in patients with underlying heart failure or chronic obstructive pulmonary disease, particularly when bronchospasm is part of the picture. However, several studies showing a benefit have been performed, particularly with the relatively cardioselective agent",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39417?source=see_link\">",
"     metoprolol",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/28-30\">",
"     28-30",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/37/40536?source=see_link\">",
"     Esmolol",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/11/37047?source=see_link\">",
"     acebutolol",
"    </a>",
"    have also been used in small numbers of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/31-33\">",
"     31-33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pooled data from the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39417?source=see_link\">",
"     metoprolol",
"    </a>",
"    studies revealed an average decrease in ventricular rate of 51 beats per minute, with 79 percent patients reverting to a sinus rhythm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1\">",
"     1",
"    </a>",
"    ]. Side effects were few, but long-term therapy is required in about one-quarter of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We use the following protocol for intravenous (IV)",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39417?source=see_link\">",
"     metoprolol",
"    </a>",
"    (",
"    <a class=\"graphic graphic_table graphicRef83358 \" href=\"mobipreview.htm?10/28/10700\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/29\">",
"     29",
"    </a>",
"    ]. Five mg of metoprolol is administered IV over 5 minutes. This can be repeated every 10 minutes for three or four doses if tolerated (maximum IV loading dose 20 mg). In patients who are unable to receive oral medications, subsequent doses of IV metoprolol can be administered every 4 to 6 hours with the patient in a monitored setting. An advantage of metoprolol is the ease of switching to an oral preparation in a dose of 50 to 100 mg twice per day. Beta blockers should generally not be given to patients with acute decompensated heart failure, severe reactive pulmonary disease, hypotension, drug hypersensitivity, and a history or ECG showing greater than first-degree heart block, bifascicular block, or serious sinus node dysfunction (unless a pacemaker is implanted).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22040828\">",
"    <span class=\"h3\">",
"     Precautions with verapamil and beta blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"     Verapamil",
"    </a>",
"    and beta blockers should",
"    <strong>",
"     not be given",
"    </strong>",
"    to patients with sinus node dysfunction or preexisting second- or third-degree block unless a temporary or permanent pacemaker has been implanted. Verapamil should be administered cautiously in patients with preexisting heart failure or hypotension as it has both negative inotropic and peripheral vasodilator activity, potentially leading to a reduction in blood pressure or even significant hypotension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/16,25\">",
"     16,25",
"    </a>",
"    ]. Beta blockers should also be administered cautiously in patients with acutely decompensated heart failure. Verapamil and beta blockers should either be avoided or used at lower doses and with caution in patients already treated with a beta blocker, verapamil or another calcium channel blocker, or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3704?source=see_link\">",
"     \"Major side effects of beta blockers\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/12/32966?source=see_link\">",
"     \"Major side effects and safety of calcium channel blockers\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23844633\">",
"    <span class=\"h3\">",
"     Which to use first: Calcium channel blocker or beta blocker?",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision to use a non-dihydropyridine calcium channel blocker or a beta blocker is most often determined by the presence or absence of heart failure and bronchospasm. We prefer",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39417?source=see_link\">",
"     metoprolol",
"    </a>",
"    before",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    in patients without these complications. In a randomized, double-blind study of 13 patients, the incidence of benefit was 89 percent with metoprolol versus 44 percent with verapamil [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, we prefer to begin with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    (or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/16/12554?source=see_link\">",
"     diltiazem",
"    </a>",
"    ) in patients with",
"    <span class=\"nowrap\">",
"     bronchospasm/advanced",
"    </span>",
"    COPD. Beta blockers may be used cautiously in some patients with heart failure, but bronchospasm is a contraindication.",
"   </p>",
"   <p>",
"    In either case, repletion of electrolyte deficiencies (hypomagnesemia and hypokalemia) should occur simultaneously. (See",
"    <a class=\"local\" href=\"#H754567\">",
"     'Magnesium and potassium repletion'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H754595\">",
"    <span class=\"h2\">",
"     Antiarrhythmic drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with symptomatic MAT that remains inadequately rate-controlled following treatment of the underlying disorder and initiation of rate controlling therapy, we do",
"    <strong>",
"     not",
"    </strong>",
"    use an antiarrhythmic drug. This is based on extensive literature showing a general lack of efficacy of standard antiarrhythmic drugs in treating MAT. Ineffective drugs include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/48/777?source=see_link\">",
"     quinidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/34/36391?source=see_link\">",
"     procainamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    , among others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1\">",
"     1",
"    </a>",
"    ]. Digitalis also appears to have little benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/2,12\">",
"     2,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/32/13829?source=see_link\">",
"     Ibutilide",
"    </a>",
"    has been used successfully to treat MAT in one elderly patient, but more experience with this drug is need [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/11/40118?source=see_link\">",
"     \"Therapeutic use of ibutilide\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H754602\">",
"    <span class=\"h2\">",
"     DC cardioversion",
"    </span>",
"    &nbsp;&mdash;&nbsp;DC cardioversion has not proven effective in converting MAT into a sinus rhythm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/12,35\">",
"     12,35",
"    </a>",
"    ]. As such, we do",
"    <strong>",
"     not",
"    </strong>",
"    perform cardioversion for patients with symptomatic MAT that remains inadequately rate-controlled.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H754609\">",
"    <span class=\"h2\">",
"     Radiofrequency ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ablation of the AV node and the use of a permanent ventricular pacemaker is an option for patients with ongoing symptomatic MAT who do not respond to, or cannot tolerate, pharmacologic therapy.",
"   </p>",
"   <p>",
"    Since most of the symptoms associated with MAT are due to the rapid ventricular rate, an alternative approach for rate control is radiofrequency modification of the AV junction, similar to the approach taken for rate control in atrial fibrillation. Ablation to cure MAT is rarely indicated and not likely to be effective given the underlying diffuse atrial abnormalities. Early data concerning radiofrequency modification of the AV node were encouraging, but modification of AV transmission without producing complete heart block is unreliable.",
"   </p>",
"   <p>",
"    AV node modification with ablation was evaluated in one study of 13 patients with chronic obstructive lung disease and medically refractory MAT who underwent AV junctional modification [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38216/abstract/36\">",
"     36",
"    </a>",
"    ]. This procedure resulted in adequate control of the ventricular response rate in 84 percent of patients, and the rate was reduced from an average of 145 to 89 beats per minute. One patient developed complete heart block, and one patient had recurrent symptomatic MAT, requiring a second procedure. After a six-month follow-up, all patients with successful modification had an improved quality of life, a reduction in symptoms, and an increase in left ventricular ejection fraction. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/25/19866?source=see_link\">",
"     \"Catheter ablation of cardiac arrhythmias: Overview and technical aspects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/41/33431?source=see_link\">",
"     \"Catheter ablation of atrial tachycardia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/53/24408?source=see_link\">",
"     \"Control of ventricular rate in atrial fibrillation: Nonpharmacologic therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H754616\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Multifocal atrial tachycardia (MAT) is an arrhythmia that can be seen in a variety of clinical disorders in adults, children, and infants. In addition to a heart rate &gt;100 beats per minute, the characteristic electrocardiographic feature in MAT is variability in P wave morphology, with three or more distinct P wave morphologies. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some patients have similar electrocardiographic (ECG) findings with multiple P wave morphologies but do not meet criteria for tachycardia. The arrhythmia is called a multifocal atrial rhythm or wandering atrial pacemaker if the rate is between 60 and 100 beats per minute. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Terminology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MAT is associated with significant lung disease in roughly 60 percent of cases and is identified in up to 20 percent of patients hospitalized for acute respiratory failure. MAT can also occur in the presence of coronary, valvular, hypertensive and other types of heart disease, particularly when associated with heart failure",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      underlying lung disease. (See",
"      <a class=\"local\" href=\"#H23843900\">",
"       'Associated clinical conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In most cases, the clinical manifestations of MAT differ from those of other tachyarrhythmias in that symptoms predominantly relate to the underlying precipitating illness rather than the arrhythmia. Patients have an irregular heart rate greater than 100 beats per minute, usually identified only during the physical exam by the health care provider, and they rarely present with symptoms of palpitations, presyncope, or syncope as the sole manifestation of MAT. (See",
"      <a class=\"local\" href=\"#H23844503\">",
"       'Clinical manifestations and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of MAT can be suspected from the presence of an irregular rapid pulse and heartbeat on physical examination; however, the diagnosis cannot be confirmed without an electrocardiogram (ECG). A diagnosis of MAT requires the following be present on the ECG (",
"      <a class=\"graphic graphic_waveform graphicRef70173 \" href=\"mobipreview.htm?13/22/13671\">",
"       waveform 1",
"      </a>",
"      ): (See",
"      <a class=\"local\" href=\"#H23844503\">",
"       'Clinical manifestations and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Discrete P waves with at least",
"      <strong>",
"       three",
"      </strong>",
"      different morphologies (including the normal sinus P wave)",
"     </li>",
"     <li>",
"      An atrial rate greater than 100 beats per minute",
"     </li>",
"     <li>",
"      P waves which are separated by isoelectric intervals",
"     </li>",
"     <li>",
"      P-P intervals, P-R duration, and R-R intervals which vary",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most episodes of MAT do not precipitate hemodynamic compromise or limiting symptoms. Thus, therapy in patients with MAT should be aimed at the inciting underlying disease. (See",
"      <a class=\"local\" href=\"#H754560\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with MAT and associated hypokalemia or hypomagnesemia should undergo electrolyte repletion prior to the initiation of additional medical therapy for MAT. (See",
"      <a class=\"local\" href=\"#H754567\">",
"       'Magnesium and potassium repletion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Medical therapy for MAT is indicated only if MAT causes a sustained rapid ventricular response that causes or worsens myocardial ischemia, heart failure, peripheral perfusion, or oxygenation. Options for medical therapy for patients with symptomatic MAT requiring ventricular rate control include non-dihydropyridine calcium channel blockers and beta blockers. For patients without heart failure or bronchospasm, we suggest initial therapy with a beta blocker, usually",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39417?source=see_link\">",
"       metoprolol",
"      </a>",
"      , before calcium channel blockers (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Conversely, for patients with severe bronchospasm, we suggest initial therapy with a non-dihydropyridine calcium channel blocker, usually",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"       verapamil",
"      </a>",
"      , rather than a beta blocker (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Beta blockers may be used cautiously in some patients with heart failure. (See",
"      <a class=\"local\" href=\"#H754574\">",
"       'Pharmacologic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Extensive literature has shown a lack of efficacy of numerous standard antiarrhythmic drugs (including",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/48/777?source=see_link\">",
"       quinidine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/34/36391?source=see_link\">",
"       procainamide",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/27/29113?source=see_link\">",
"       digoxin",
"      </a>",
"      ) as well as electrical cardioversion in treating MAT. (See",
"      <a class=\"local\" href=\"#H754595\">",
"       'Antiarrhythmic drugs'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H754602\">",
"       'DC cardioversion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ablation of the AV node and the use of a permanent ventricular pacemaker is an option for patients with ongoing symptomatic MAT who do not respond to or cannot tolerate pharmacologic therapy. (See",
"      <a class=\"local\" href=\"#H754609\">",
"       'Radiofrequency ablation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/1\">",
"      Kastor JA. Multifocal atrial tachycardia. N Engl J Med 1990; 322:1713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/2\">",
"      Shine KI, Kastor JA, Yurchak PM. Multifocal atrial tachycardia. Clinical and electrocardiographic features in 32 patients. N Engl J Med 1968; 279:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/3\">",
"      Berlinerblau R, Feder W. Chaotic atrial rhythm. J Electrocardiol 1972; 5:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/4\">",
"      Bisset GS 3rd, Seigel SF, Gaum WE, Kaplan S. Chaotic atrial tachycardia in childhood. Am Heart J 1981; 101:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/5\">",
"      Gavrilescu S, Luca C. Chaotic atrial rhythm: Studies with His bundle electrography. Eur J Cardiol 1974; 2:153.",
"     </a>",
"    </li>",
"    <li>",
"     Glass L, Mackey MC. From Clocks to Chaos: The Rhythms of Life, Princeton University Press, Princeton, NJ 1988.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/7\">",
"      Kothari SA, Apiyasawat S, Asad N, Spodick DH. Evidence supporting a new rate threshold for multifocal atrial tachycardia. Clin Cardiol 2005; 28:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/8\">",
"      Marchlinski FE, Miller JM. Atrial arrhythmias exacerbated by theophylline. Response to verapamil and evidence for triggered activity in man. Chest 1985; 88:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/9\">",
"      Levine JH, Michael JR, Guarnieri T. Treatment of multifocal atrial tachycardia with verapamil. N Engl J Med 1985; 312:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/10\">",
"      Santos-Ocampo CD, Sadaniantz A, Elion JL, et al. Echocardiographic assessment of the cardiac anatomy in patients with multifocal atrial tachycardia: a comparison with atrial fibrillation. Am J Med Sci 1994; 307:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/11\">",
"      Engel TR, Radhagopalan S. Treatment of multifocal atrial tachycardia by treatment of pulmonary insufficiency: or is it vice versa? Chest 2000; 117:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/12\">",
"      Wang K, Goldfarb BL, Gobel FL, Richman HG. Multifocal atrial tachycardia. Arch Intern Med 1977; 137:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/13\">",
"      Lipson MJ, Naimi S. Multifocal atrial tachycardia (chaotic atrial tachycardia). Clinical associations and significance. Circulation 1970; 42:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/14\">",
"      Hudson LD, Kurt TL, Petty TL, Genton E. Arrhythmias associated with acute respiratory failure in patients with chronic airway obstruction. Chest 1973; 63:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/15\">",
"      Levine JH, Michael JR, Guarnieri T. Multifocal atrial tachycardia: a toxic effect of theophylline. Lancet 1985; 1:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/16\">",
"      Hazard PB, Burnett CR. Verapamil in multifocal atrial tachycardia. Hemodynamic and respiratory changes. Chest 1987; 91:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/17\">",
"      Tutar E, Kaya A, G&uuml;le&ccedil; S, et al. Echocardiographic evaluation of left ventricular diastolic function in chronic cor pulmonale. Am J Cardiol 1999; 83:1414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/18\">",
"      Moustapha A, Kaushik V, Diaz S, et al. Echocardiographic evaluation of left-ventricular diastolic function in patients with chronic pulmonary hypertension. Cardiology 2001; 95:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/19\">",
"      Iseri LT, Fairshter RD, Hardemann JL, Brodsky MA. Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J 1985; 110:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/20\">",
"      Phillips J, Spano J, Burch G. Chaotic atrial mechanism. Am Heart J 1969; 78:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/21\">",
"      Chung EK. Appraisal of multifocal atrial tachycardia. Br Heart J 1971; 33:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/22\">",
"      McCord JK, Borzak S, Davis T, Gheorghiade M. Usefulness of intravenous magnesium for multifocal atrial tachycardia in patients with chronic obstructive pulmonary disease. Am J Cardiol 1998; 81:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/23\">",
"      Strickberger SA, Miller CB, Levine JH. Multifocal atrial tachycardia from electrolyte imbalance. Am Heart J 1988; 115:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/24\">",
"      Parrillo JE. Treating multifocal atrial tachycardia (MAT) in a critical care unit: New data regarding verapamil and metoprolol. Update Crit Care Med 1987; 2:1, 3-5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/25\">",
"      Schettini B, Katz S, Zeldis SM. Verapamil in tachycardia therapy. Chest 1986; 89:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/26\">",
"      Mukerji V, Alpert MA, Diaz-Arias M, Sanfelippo JF. Termination and suppression of multifocal atrial tachycardia with verapamil. South Med J 1987; 80:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/27\">",
"      Salerno DM, Anderson B, Sharkey PJ, Iber C. Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment. Ann Intern Med 1987; 107:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/28\">",
"      Hanau SP, Solar M, Arsura EL. Metoprolol in the treatment of multifocal atrial tachycardia. Cardiovasc Rev Rep 1984; 5:1182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/29\">",
"      Arsura EL, Solar M, Lefkin AS, et al. Metoprolol in the treatment of multifocal atrial tachycardia. Crit Care Med 1987; 15:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/30\">",
"      Hazard PB, Burnett CR. Treatment of multifocal atrial tachycardia with metoprolol. Crit Care Med 1987; 15:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/31\">",
"      Byrd RC, Sung RJ, Marks J, Parmley WW. Safety and efficacy of esmolol (ASL-8052: an ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardias. J Am Coll Cardiol 1984; 3:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/32\">",
"      Aronow WS, Van Camp S, Turbow M, et al. Acebutolol in supraventricular arrhythmias. Clin Pharmacol Ther 1979; 25:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/33\">",
"      Williams DO, Tatelbaum R, Most AS. Effective treatment of supraventricular arrhythmias with acebutolol. Am J Cardiol 1979; 44:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/34\">",
"      Pierce WJ, McGroary K. Multifocal atrial tachycardia and Ibutilide. Am J Geriatr Cardiol 2001; 10:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/35\">",
"      Kones RJ, Phillips JH, Hersh J. Mechanism and management of chaotic atrial mechanism. Cardiology 1974; 59:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38216/abstract/36\">",
"      Ueng KC, Lee SH, Wu DJ, et al. Radiofrequency catheter modification of atrioventricular junction in patients with COPD and medically refractory multifocal atrial tachycardia. Chest 2000; 117:52.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 901 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-217.117.136.88-094BD8D684-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38216=[""].join("\n");
var outline_f37_20_38216=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H754616\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION, PATHOGENESIS, AND PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Terminology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Mechanisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Associated arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Prevalence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23843900\">",
"      ASSOCIATED CLINICAL CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Cardiac disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Interactions between cardiac and pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Miscellaneous",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      MAT in children and young adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23844503\">",
"      CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1117337\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H754560\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H754567\">",
"      Magnesium and potassium repletion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H754574\">",
"      Pharmacologic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H754581\">",
"      - Non-dihydropyridine calcium channel blockers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H754588\">",
"      - Beta blockers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22040828\">",
"      - Precautions with verapamil and beta blockers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23844633\">",
"      - Which to use first: Calcium channel blocker or beta blocker?",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H754595\">",
"      Antiarrhythmic drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H754602\">",
"      DC cardioversion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H754609\">",
"      Radiofrequency ablation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H754616\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/901\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/901|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/24/27023\" title=\"figure 1\">",
"      Action potential and ECG",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/901|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?10/28/10700\" title=\"table 1\">",
"      Heart rate control of MAT in COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/901|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?13/22/13671\" title=\"waveform 1\">",
"      Multifocal atrial tachycardia ECG",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/21/8538?source=related_link\">",
"      Arrhythmias in COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/34/16937?source=related_link\">",
"      Atrial tachycardias in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24793?source=related_link\">",
"      Atrioventricular nodal reentrant tachycardia (junctional reciprocating tachycardia)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/47/24311?source=related_link\">",
"      Atrioventricular reentrant tachycardia (AVRT) associated with an accessory pathway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/41/33431?source=related_link\">",
"      Catheter ablation of atrial tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/25/19866?source=related_link\">",
"      Catheter ablation of cardiac arrhythmias: Overview and technical aspects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/22/43368?source=related_link\">",
"      Clinical manifestations and diagnosis of diastolic heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/2/9258?source=related_link\">",
"      Clinical manifestations and treatment of hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/35/39481?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of narrow QRS complex tachycardias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/53/24408?source=related_link\">",
"      Control of ventricular rate in atrial fibrillation: Nonpharmacologic therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/56/12165?source=related_link\">",
"      Electrocardiographic and electrophysiologic features of type II atrial flutter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/22/21864?source=related_link\">",
"      Focal atrial tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/12/32966?source=related_link\">",
"      Major side effects and safety of calcium channel blockers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3704?source=related_link\">",
"      Major side effects of beta blockers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/22/361?source=related_link\">",
"      Overview of atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/47/19193?source=related_link\">",
"      Overview of pulmonary hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/37/42580?source=related_link\">",
"      Signs and symptoms of magnesium depletion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27097?source=related_link\">",
"      Tachycardia-mediated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/42/26278?source=related_link\">",
"      The electrocardiogram in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/11/40118?source=related_link\">",
"      Therapeutic use of ibutilide",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_20_38217="Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection";
var content_f37_20_38217=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/20/38217/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/20/38217/contributors\">",
"     Peter A Leone, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/20/38217/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/20/38217/contributors\">",
"     Noreen A Hynes, MD, MPH, DTM&amp;H",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/20/38217/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/20/38217/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/20/38217/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gonorrhea is the second most commonly reported communicable disease in the United States, accounting for more than 300,000 cases annually and probably an equal number of cases that are unreported. Gonorrhea is a major cause of urethritis in men and cervicitis in women; the latter can result in pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/3/19514?source=see_link\">",
"     \"Treatment of uncomplicated gonococcal infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/35/26166?source=see_link\">",
"     \"Diagnosis of gonococcal infections\"",
"    </a>",
"    .) Invasive infections with Neisseria gonorrhoeae, including disseminated gonococcal infection, endocarditis, and meningitis, are uncommon but can result in serious morbidity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/56/3976?source=see_link\">",
"     \"Disseminated gonococcal infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology of gonococcal infections in the United States has undergone major changes in recent years. Overall rates have declined since the mid-1970s, reaching an all-time low of 116.2 cases per 100,000 in 2003 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/2\">",
"     2",
"    </a>",
"    ]. However, major racial disparities remain and increases in antibiotic resistance continue, with resistance to fluoroquinolones an important problem in several states.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Trends in gonorrhea rates",
"    </span>",
"    &nbsp;&mdash;&nbsp;The highest reported rates of gonococcal infection are seen among adolescents and young adults, minorities, and persons living in the southeastern United States. Reported rates of gonococcal infection have also historically been higher in men than in women, a difference ascribed mainly to the higher rate of asymptomatic disease in women and the occurrence of infection among MSM. Increased active case finding in women beginning in the 1970s and the decrease in cases among MSM since the 1980s has resulted in a nearly equal ratio of cases in men and women nationally (160,106 versus 174,230 in 2003 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/2\">",
"     2",
"    </a>",
"    ]).",
"   </p>",
"   <p>",
"    An analysis of reported gonorrhea cases in the United States demonstrated that, although gonorrhea rates decreased by more than 70 percent between 1981 and 1996, rates remained high in specific subpopulations (",
"    <a class=\"graphic graphic_figure graphicRef70456 \" href=\"mobipreview.htm?16/10/16558\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/3\">",
"     3",
"    </a>",
"    ]. This analysis and more data indicate that [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rates were highest in women ages 15 to 19 years (634.7 cases per 100,000 population in 2003) and men aged 20 to 24 years (465.9 cases per 100,000 population in 2003). Furthermore, rates among 15 to 19 year-olds declined less since 1981 than rates among older persons (",
"      <a class=\"graphic graphic_figure graphicRef70456 \" href=\"mobipreview.htm?16/10/16558\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The rate of infection also declined among blacks, but less so than in whites. Rates among blacks were 20 times higher in 2003, respectively, compared with 11 times higher in 1981. In 2003, the reported rates among blacks and whites were 655.8 and 32.7 cases per 100,000 population.",
"      <br/>",
"      <br/>",
"      Reasons for the racial disparity in gonorrhea rates are not well understood but probably include differences in health services access and utilization, geographic clustering of populations, other interrelated social and economic factors, and sexual partner choices along both socioeconomic and racial lines [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/4\">",
"       4",
"      </a>",
"      ]. In addition, differential reporting by public and private health care providers may magnify the racial differences [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Despite decreases since 1981, rates in southeastern states were consistently higher than rates in other areas of the country (",
"      <a class=\"graphic graphic_figure graphicRef59206 \" href=\"mobipreview.htm?16/13/16598\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional information on the incidence of gonorrhea is available online at:",
"    <a class=\"external\" href=\"file://www.cdc.gov/std\">",
"     www.cdc.gov/std",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    It is likely that multiple factors contributed to the decrease in gonorrhea rates over the last three decades. Screening programs that incorporate on-site single-dose therapy have probably been important since the early 1970s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/3\">",
"     3",
"    </a>",
"    ]. In addition, a shift in the age distribution of the United States population has meant that a decreasing proportion of people fall into the highest risk age groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Changes in sexual behavior in response to the HIV epidemic may also be important. Several reports indicated that MSM reduced risky sexual practices in the mid-1980s and had lower rates of rectal gonorrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/5\">",
"     5",
"    </a>",
"    ]. Although evidence for sexual behavior risk-reduction in response to the HIV epidemic among heterosexuals is limited, increased condom use has been documented [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the trend toward safer sexual practices among MSM may be reversing. Gonorrhea in MSM is accounting for a rapidly increasing proportion of all gonorrhea cases in several major cities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/7\">",
"     7",
"    </a>",
"    ]. Men who have sex with men (MSM) appear to have an increased rate of gonococcal infection due to resistant isolates than men who have sex exclusively with women (MSW), likely because MSM sexual networks are more likely to have circulating antibiotic-resistant strains than MSW networks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/8\">",
"     8",
"    </a>",
"    ]. These increases in gonorrhea are consistent with increases in the numbers of MSM engaging in sexual risk behaviors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/9\">",
"     9",
"    </a>",
"    ]. Among MSM, most rectal infections (84 percent in one report) were asymptomatic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gonorrhea has an important epidemiologic relationship with HIV. First, the acquisition of gonococcal infection implies risky sexual behavior; second the presence of gonococcal infection appears to facilitate both the transmission and acquisition of HIV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. In a study from Malawi, for example, urethritis, particularly due to gonorrhea, was associated with eightfold higher concentrations of HIV-1 RNA in semen than in HIV-infected men without urethritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/12\">",
"     12",
"    </a>",
"    ]. Furthermore, treatment of the urethritis lowered HIV-1 RNA by two-thirds.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Risk factors and attack rate for gonorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors and risk markers for gonorrhea include recent new sexual partner or multiple sexual partners, being unmarried, young age, minority ethnicity, low educational and socioeconomic levels, substance abuse, and previous gonorrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. Geographic clustering of gonorrhea coincides with geographic clustering of many of these risk markers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/16\">",
"     16",
"    </a>",
"    ]. Combinations of these markers have been used to identify persons for screening for asymptomatic gonococcal infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data on the attack rate after exposure to an infected partner have produced somewhat variable results. In one study of 26 women with recent exposure to Neisseria gonorrhoeae, the attack rate was 50 percent with one documented exposure to an infected male sexual partner and increased to 93 percent with repeated exposures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/17\">",
"     17",
"    </a>",
"    ]. In comparison, a later study of 76 women exposed to either chlamydia or gonorrhea found a transmission rate of 73 percent among the 45 women with exposure to gonorrhea only, and the number of encounters did not increase the risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Molecular epidemiology of gonorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infections with N. gonorrhoeae are caused by a large number of different strains. Strains are typically characterized by several methods:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serotyping, which is based upon variations in the major outer membrane protein (protein I, or porin)",
"     </li>",
"     <li>",
"      Auxotyping, which identifies the strain's growth requirements",
"     </li>",
"     <li>",
"      Antimicrobial susceptibility profiles.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These methods have demonstrated remarkable strain diversity within and among geographic areas, with a small number of",
"    <span class=\"nowrap\">",
"     auxotype/serotype",
"    </span>",
"    classes predominating in most communities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/19\">",
"     19",
"    </a>",
"    ]. Additional characterization through pulsed field gel electrophoresis and amplification of various genetic markers, including genes for protein I and another outer membrane protein, Opa (see",
"    <a class=\"local\" href=\"#H21428192\">",
"     'Pathogenesis'",
"    </a>",
"    below), have allowed further discrimination of strains and have been used in outbreak investigations and to identify sexual partner pairs or transmission networks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/20-24\">",
"     20-24",
"    </a>",
"    ]. However, these molecular techniques are not part of the standard clinical diagnostic armamentarium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Epidemiology of antimicrobial resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over time, N. gonorrhoeae has developed increasing minimum inhibitory concentrations (ie, decreasing susceptibility) followed by frank resistance to the antimicrobial classes most commonly used for therapy, thus progressively reducing available therapeutic options [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/25\">",
"     25",
"    </a>",
"    ]. Domestic and international gonococcal surveillance efforts have demonstrated increased resistance worldwide to multiple classes of antibiotics, including penicillins, tetracyclines, macrolides, and fluoroquinolones, with documented cross-resistance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. An especially alarming trend in N. gonorrhoeae drug resistance has been the progressive decrease in susceptibility to the cephalosporins. Further details of N. gonorrhoeae drug resistance are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/3/19514?source=see_link&amp;anchor=H7889004#H7889004\">",
"     \"Treatment of uncomplicated gonococcal infections\", section on 'Antibiotic resistance'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21428192\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection with N. gonorrhoeae encompasses four specific stages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Attachment to the mucosal cell surface",
"     </li>",
"     <li>",
"      Local penetration or invasion",
"     </li>",
"     <li>",
"      Local proliferation",
"     </li>",
"     <li>",
"      Local inflammatory response or dissemination",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21428214\">",
"    <span class=\"h2\">",
"     Attachment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial attachment of gonococci to the surface of columnar epithelial cells is mediated by pili, which are filamentous outer membrane appendages composed of multiple subunits, the most important of which is pilin or pilE which forms the pilus fiber (",
"    <a class=\"graphic graphic_figure graphicRef63651 \" href=\"mobipreview.htm?4/26/4527\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/31\">",
"     31",
"    </a>",
"    ]. Human challenge studies suggest pili are important for infection and that anti-pilin antibodies can block binding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/32\">",
"     32",
"    </a>",
"    ]. Previous studies have suggested Pil-negative variants are noninfectious [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other outer membrane structures involved in gonococci attachment include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PilC proteins &mdash; PilC1 and PilC2 are proteins that copurify with pilin. They play a key role in epithelial cell adherence, but there is uncertainty about how they interact with pilin, or why they assist with cell attachment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]. The PilC protein is located at the tip of the pili; furthermore, binding of PilC competes with pilus-mediated but not Opa-mediated attachment to human epithelial cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Opa (opacity related proteins or protein II) is a family of 11 or 12 related proteins that increase colony opacity of N. gonorrhoeae when viewed under a dissecting microscope [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/38\">",
"       38",
"      </a>",
"      ]. Opa proteins undergo frequent phase and antigenic variation, and only a few Opa types appear to be able to mediate cellular attachment or induce endocytosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/39,40\">",
"       39,40",
"      </a>",
"      ]. The clinical importance of Opa is suggested by the observation in one study that infected women who had anti-Opa antibodies had a lower risk of gonococcal salpingitis (adjusted odds ratio 0.35) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    CD66 is the epithelial cell receptor for binding Opa ligands [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/42\">",
"     42",
"    </a>",
"    ]. Expression of different members of the CD66 family may explain preferential binding of gonococci to particular cells, since various Opa variants exhibit different binding specificities for various CD66 family members [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/42,43\">",
"     42,43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21428221\">",
"    <span class=\"h2\">",
"     Local invasion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local invasion initially involves multiple adhesins, as described above, which interact with a variety of host receptors. As an example, Opa binds to heparan sulfate proteoglycan receptors on host cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following attachment to mucosal cells, gonococci become engulfed in a process known as parasite-directed endocytosis. This process may involve activation of acidic sphingomyelinase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/45\">",
"     45",
"    </a>",
"    ] and appears to be enhanced by Protein I or Por [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. Porins are trimeric protein structures that form anion-selective transmembrane channels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. There are two structurally related forms, Por A and Por B.",
"   </p>",
"   <p>",
"    Purified Por exhibits several functions believed to be important in cellular invasion:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The ability to insert itself into the host cell membranes",
"     </li>",
"     <li>",
"      The ability to bind calmodulin",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These functions make it possible to induce endocytosis into epithelial cells, blunt polymorphonuclear leukocyte oxidative burst, and block phagolysosomal fusion.",
"   </p>",
"   <p>",
"    Gonococci are able to undergo intracellular replication, both within phagocytic vacuoles and within columnar epithelial cells. Gonococci grow in both aerobic and anaerobic environments. This adaptive response allows it to function as a facilitative intracellular parasite in endothelial cells and survive and replicate within leukocyte phagolysosomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/50-52\">",
"     50-52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21428228\">",
"    <span class=\"h2\">",
"     Dissemination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal human serum can kill circulating gonococci via the activation of complement and the deposition of terminal complement complex on the cell surface. However, disseminated gonococcal isolates are typically serum resistant and can induce defective deposition of the terminal complement complex on the outer membranes. Por A appears to be crucial to the development of serum resistance since most invasive strains express Por A [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/53\">",
"     53",
"    </a>",
"    ]. In comparison, Por A may be less important for other complications such as epididymitis in men and pelvic inflammatory disease in women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21428235\">",
"    <span class=\"h2\">",
"     Adaptation to evade host immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;In order for Neisseria gonorrhoeae to survive the host immune response, it has developed complex strategies to avoid host defense mechanisms. Examples of these strategies include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antigenic and phase variation of Opa, Pil, and lipooligosaccharide (LOS) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/54-57\">",
"       54-57",
"      </a>",
"      ]. As an example, multiple pilin antigenic variants are produced during infection, which help to avoid the immune response [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Masking of gonococcal antigen (sialylation of LOS) which prevents the binding of bactericidal antibodies and the activation of complement [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/58,59\">",
"       58,59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mimicry (as demonstrated by the similarity of terminal LOS sugars to host glycolipids)",
"     </li>",
"     <li>",
"      Release of IgA1 proteases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/60\">",
"       60",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Blocking antigen by the binding of antibodies to a reduction modifiable protein (Rmp). Rmp is physically associated with Por on the outer membrane of gonococci and is highly immunogenic for noncomplement-fixing antibodies. Antibodies directed against Rmp bind to the Por-Rmp complex, and block the effective deposition of complement-fixing anti-Por antibodies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/61\">",
"       61",
"      </a>",
"      ]. Compatible with these experimental findings is the clinical observation that women infected with Neisseria gonorrhoeae who produced Rmp antibodies had an increased risk of salpingitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/41,62\">",
"       41,62",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Por has been used for determining serovars of N. gonorrhoeae and has been targeted as a vaccine candidate since there is some evidence that this major structural protein is immunogenic in natural infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/63\">",
"     63",
"    </a>",
"    ]. However, one study of the gene sequences of Por detected diversity in strains of the same serovar within a community although 65 percent of reinfections were caused by organisms with the same porin type [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5248334\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS IN WOMEN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gonorrhea in women can involve any portion of the genital tract, the oropharynx or become disseminated. Infection in women is often asymptomatic compared to men who are asymptomatic only 10 percent of the time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5248342\">",
"    <span class=\"h2\">",
"     Cervical infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common site of mucosal infection with N. gonorrhoeae is the cervix. Approximately 50 percent of infected women with cervical infection are asymptomatic. Symptomatic infection typically manifests as vaginal pruritus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a mucopurulent discharge. On examination, the cervix may appear normal or show signs of frank discharge. The cervical mucosa is often friable, and evidence of concurrent upper genital tract disease (abdominal pain, dyspareunia) may be present. Pain is atypical in the absence of upper tract infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5248350\">",
"    <span class=\"h2\">",
"     Urethritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gonococcal urethritis can occur in the absence of pelvic inflammatory disease and is responsible for up to 10 percent of cases of dysuria among inner-city women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5248357\">",
"    <span class=\"h2\">",
"     Anorectal infection and proctitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anorectal gonococcal infection can be asymptomatic or associated with clinical proctitis. In one study, 127 women exposed to gonorrhea underwent proctoscopy and 50 percent were found to be anorectally infected with N. gonorrhoeae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/66\">",
"     66",
"    </a>",
"    ]. Of these 63 women, 46 percent had concomitant urethral and cervical infection, while 6 percent had infection confined to the rectum. A second study reported anorectal involvement in 44 percent of women with uncomplicated gonorrhea and as the sole site of infection in 4 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/67\">",
"     67",
"    </a>",
"    ]. It is unclear whether anorectal infection results from direct contact with penile secretions from infected male partners or autoinoculation from vaginal secretions.",
"   </p>",
"   <p>",
"    The vast majority of anorectal infections are asymptomatic. Only 3 percent of cases present with symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/67\">",
"     67",
"    </a>",
"    ], including anal itching, rectal discharge, rectal fullness and painful defecation. It is not necessary to perform proctoscopy to make this diagnosis. In one study of 228 women with gonorrhea, culture of the anal canal using a blind swab technique was as reliable as rectal swab samples collected under direct visualization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5248365\">",
"    <span class=\"h2\">",
"     Oropharyngeal infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gonococcus isolated from the oropharynx typically represents asymptomatic colonization, although symptomatic pharyngitis can also occur. From studies in consecutive women presenting to STD clinics, the prevalence of pharyngeal gonorrhea is estimated at two to six percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. However, when gonorrhea is detected at another site, the incidence of pharyngeal involvement increases to 5 to 20 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/71\">",
"     71",
"    </a>",
"    ]. The risk for pharyngeal gonorrhea may be increased in pregnant women with infection at another site despite the lower prevalence of pharyngeal involvement in prenatal patients compared to STD clinic populations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/69\">",
"     69",
"    </a>",
"    ].",
"    <strong>",
"    </strong>",
"    A prospective prevalence study of 239 patients with sore throat presenting to three general medicine clinics found that one percent of both female and male patients were culture positive for N. gonorrhoeae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for pharyngeal gonorrhea include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A history of fellatio or cunnilingus",
"     </li>",
"     <li>",
"      A sexual partner with gonorrhea",
"     </li>",
"     <li>",
"      Pregnancy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Gram stain of pharyngeal secretions cannot be used for the diagnosis of gonorrhea because non-pathogenic Neisseria species occur in the oropharynx. Culture remains the most practical method of diagnosing oropharyngeal gonorrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5248373\">",
"    <span class=\"h2\">",
"     Other mucosal sites of infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bartholin glands and Skene's glands can also become infected with N. gonorrhoeae in women. These sites typically are symptomatic and rarely the sole site of infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5248381\">",
"    <span class=\"h2\">",
"     Pelvic inflammatory disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic inflammatory disease (PID) occurs in approximately 10 to 40 percent of women with cervical gonorrhea. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/45/11992?source=see_link\">",
"     \"Pathogenesis of and risk factors for pelvic inflammatory disease\"",
"    </a>",
"    .) Gonorrhea is estimated to be the causative organism in 40 percent of cases of PID [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/73,74\">",
"     73,74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the high incidence of asymptomatic gonococcal infection in women, PID can be the first presenting complaint. Significant scarring and inflammation due to PID may be present in the absence of fulminant symptoms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=see_link\">",
"     \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"    </a>",
"    .) Symptoms of PID include",
"    <span class=\"nowrap\">",
"     pelvic/abdominal",
"    </span>",
"    pain, abnormal vaginal bleeding, and dyspareunia. Often symptoms occur with the onset of menses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/73\">",
"     73",
"    </a>",
"    ]. Although approximately 50 percent of all patients with PID have fever, this sign may be more common in patients with PID caused by N. gonorrhoeae. However, the absence of fever does not exclude the diagnosis. Signs of PID on examination include uterine tenderness, adnexal or cervical motion tenderness, but these do not distinguish between gonococcal versus nongonococcal etiologies.",
"   </p>",
"   <p>",
"    Fitz-Hugh Curtis syndrome or perihepatitis associated with PID was first described with gonococcal infection; this syndrome can also be caused by Chlamydia. Symptoms and signs include right upper quadrant pain and tenderness. Liver function tests are frequently abnormal.",
"   </p>",
"   <p>",
"    Several risk factors have been associated with PID, although none have been specifically linked to PID caused by gonorrhea.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study found that women in the proliferative phase of their menstrual cycle had an adjusted odds ratio of 4.5 for the development of PID [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/75\">",
"       75",
"      </a>",
"      ]. Douching, race, multiple sexual partners or the use of barrier methods of birth control were not significant risk factors.",
"     </li>",
"     <li>",
"      Another series found parity greater than 0 (OR 4.44), greater than one sexual partner in the last 30 days (OR 11.08), sexual contact during previous menses (OR 5.22), and lack of contraception (OR 7.6) to be significant risks for the development of PID [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/76\">",
"       76",
"      </a>",
"      ]. While there was a tendency for the association between douching and PID, it was not statistically significant.",
"     </li>",
"     <li>",
"      A third study did note an association between current douching and PID [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/77\">",
"       77",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnosis of PID is usually made on clinical rather than pathological grounds. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=see_link\">",
"     \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5248641\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS IN MEN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gonococcal infections in men can involve any part of the genital tract, either alone or in combination with other sites. Genital infections are generally symptomatic in men; in one survey of 1615 male cases, only 10 percent were asymptomatic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/65\">",
"     65",
"    </a>",
"    ]. Extragenital infections (pharynx, rectum) occur more commonly in MSM. Infections at extragenital sites are usually asymptomatic, although a small proportion of patients have symptoms of pharyngitis or proctitis. Untreated gonococcal infections infrequently progress locally (periurethral abscess, acute prostatitis) or disseminate (disseminated gonococcal infection). Other complications of gonococcal urethritis in men include epididymitis, chronic prostatitis, seminal vesiculitis, and infections of Cowper's and Tyson's glands. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/38/29286?source=see_link&amp;anchor=H3288310#H3288310\">",
"     \"Cutaneous manifestations of gonorrhea\", section on 'Secondary cutaneous gonorrhea'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5248648\">",
"    <span class=\"h2\">",
"     Urethritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incubation period for Neisseria gonorrhoeae in men is most commonly described as two to five days, although one study of 228 men with a known date of infection found a mean incubation period of eight days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/65\">",
"     65",
"    </a>",
"    ]. Others have estimated that symptoms of urethritis develop in 75 percent of men within four to eight days of genital infection with N. gonorrhoeae and in 80 to 90 percent within two weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Urethritis in men is defined by the presence of characteristic symptoms and laboratory findings. The symptoms of urethritis include a penile discharge",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dysuria. The discharge is often present spontaneously at the urethral meatus, purulent or mucopurulent in color, and copious in amount. However, the discharge may also be indistinguishable on appearance from that found with nongonococcal urethritis (",
"    <a class=\"graphic graphic_picture graphicRef77674 \" href=\"mobipreview.htm?18/31/18929\">",
"     picture 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/18/18728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Urethritis is also defined by the laboratory demonstration of &gt;5 white blood cells (WBCs) per high power oil immersion field in urethral secretions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/79\">",
"     79",
"    </a>",
"    ], presence of leukocyte esterase,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    &gt;10 WBCs on microscopic examination of first void urine. However, one study of men attending an urban STD clinic, up to five percent of men diagnosed with gonorrhea had no Gram's stain evidence of urethral inflammation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Men with gonococcal urethritis may present with any combination of symptoms. In one study of 1615 episodes of gonococcal urethritis, discharge was present in 82 percent and dysuria alone in 53 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/65\">",
"     65",
"    </a>",
"    ]. In some instances, the patient may be completely asymptomatic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5248667\">",
"    <span class=\"h2\">",
"     Epididymitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unilateral testicular pain and swelling may be the sole presenting complaints of men with epididymitis, with urethritis often being discovered during the history and physical examination. Infectious causes of epididymitis must be distinguished from other causes of acute testicular pain (eg, torsion, trauma). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/20/44360?source=see_link\">",
"     \"Evaluation of the acute scrotum in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acute unilateral epididymitis can be a complication of gonococcal infection, although it is more commonly due to Chlamydia trachomatis infection, especially in patients less than 35 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/81-83\">",
"     81-83",
"    </a>",
"    ]. Combined gonococcal and chlamydial infections of the epididymis are more frequent than epididymal infections caused by N. gonorrhoeae alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5248686\">",
"    <span class=\"h2\">",
"     Proctitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anorectal gonorrheal infections are uncommon in heterosexual men; they more typically occur among men who engage in anoreceptive intercourse. Anorectal gonorrhea is the only site of infection in approximately 40 percent of MSM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/78\">",
"     78",
"    </a>",
"    ], which is of additional concern because gonococcal proctitis in MSM, is associated with an approximately three-fold increase in the risk of acquisition of HIV infection, probably due at least in part to diminished epithelial integrity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/84,85\">",
"     84,85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Symptoms of proctitis include a mucopurulent rectal discharge, tenesmus, constipation, and anorectal pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/65\">",
"     65",
"    </a>",
"    ]. Anorectal gonorrhea must be distinguished from other causes of proctitis (eg, C. trachomatis, herpes simplex virus, syphilis). The frequency of these causes was evaluated in a review of 101 episodes of proctitis among MSM in San Francisco; anoscopy was performed and specimens obtained that were tested for the above organisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/86\">",
"     86",
"    </a>",
"    ]. The following frequency of causes was noted:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      None &ndash; 45 percent",
"     </li>",
"     <li>",
"      Gonorrhea only &ndash; 20 percent",
"     </li>",
"     <li>",
"      Herpes simplex only &ndash; 13 percent",
"     </li>",
"     <li>",
"      Chlamydia only &ndash; 11 percent",
"     </li>",
"     <li>",
"      Mixed infections &ndash; 10 percent, including 8 percent with gonorrhea",
"     </li>",
"     <li>",
"      Syphilis only &ndash; 1 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5248693\">",
"    <span class=\"h2\">",
"     Pharyngitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oropharyngeal infections with N. gonorrhoeae are frequently asymptomatic, although pharyngeal exudates or cervical lymphadenitis are evident in some cases. In 2008, pharyngeal gonorrhea positivity ranged from 1 to 12 percent among MSM tested for it (64 percent of all MSM visits to STD clinics in eight cities reporting these data). Gonococcal infection of the pharynx is usually acquired by oral sexual exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/87\">",
"     87",
"    </a>",
"    ]; it is acquired more efficiently by fellatio than by cunnilingus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/65,78,88\">",
"     65,78,88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Persistence of N. gonorrhoeae in the pharynx or any mucosal site can occur after treatment and provides a potential source for DGI. N. gonorrhoeae can be isolated from a mucosal surface in the majority of patients with DGI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/20/38217/abstract/78\">",
"     78",
"    </a>",
"    ]. Whether this represents a cause or consequence of disseminated infection has not been elucidated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/56/3976?source=see_link\">",
"     \"Disseminated gonococcal infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/44/1730?source=see_link\">",
"       \"Patient information: Gonorrhea (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21428802\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The highest reported rates of gonococcal infection are seen among adolescents and young adults, minorities, and persons living in the southeastern United States. Reported rates of gonococcal infection have been historically higher in men than in women, a difference ascribed mainly to the higher rate of asymptomatic disease in women and the occurrence of infection among men who have sex with men. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for gonorrhea include a new sexual partner or multiple sexual partners, being unmarried, young age, minority ethnicity, low educational and socioeconomic levels, and history of substance abuse or previous episode of gonorrhea. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Risk factors and attack rate for gonorrhea'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infection with N. gonorrhoeae encompasses four specific stages: local attachment, invasion, dissemination, and evasion of host immunity. (See",
"      <a class=\"local\" href=\"#H21428192\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gonococcal infection in women can present as cervicitis (eg, vaginal pruritus",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a mucopurulent cervical discharge), urethritis (eg, dysuria), or anorectal infection (eg, painful defecation, anal discharge). Pelvic inflammatory disease is a complication of untreated gonococcal infection, which can lead to infertility. Symptoms of pelvic inflammatory disease include",
"      <span class=\"nowrap\">",
"       pelvic/abdominal",
"      </span>",
"      pain, abnormal vaginal bleeding, and dyspareunia. Women are at risk for complicated infection since they are more likely to have asymptomatic infection than men. (See",
"      <a class=\"local\" href=\"#H5248334\">",
"       'Clinical manifestations in women'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gonococcal infection in men can present as urethritis (eg, dysuria, penile discharge), epididymitis (testicular pain), or proctitis (painful defecation). The vast majority of men (approximately 90 percent) are symptomatic. (See",
"      <a class=\"local\" href=\"#H5248641\">",
"       'Clinical manifestations in men'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gonococcus isolated from the oropharynx typically represents asymptomatic colonization. (See",
"      <a class=\"local\" href=\"#H5248365\">",
"       'Oropharyngeal infection'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/1\">",
"      Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2003. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, November 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/3\">",
"      Fox KK, Whittington WL, Levine WC, et al. Gonorrhea in the United States, 1981-1996. Demographic and geographic trends. Sex Transm Dis 1998; 25:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/4\">",
"      Toomey KE, Moran JS, Rafferty MP, Beckett GA. Epidemiological considerations of sexually transmitted diseases in underserved populations. Infect Dis Clin North Am 1993; 7:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/5\">",
"      Handsfield HH. Decreasing incidence of gonorrhea in homosexually active men--minimal effect on risk of AIDS. West J Med 1985; 143:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/6\">",
"      Moran JS, Janes HR, Peterman TA, Stone KM. Increase in condom sales following AIDS education and publicity, United States. Am J Public Health 1990; 80:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/7\">",
"      Fox KK, del Rio C, Holmes KK, et al. Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. Am J Public Health 2001; 91:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/8\">",
"      Kirkcaldy RD, Zaidi A, Hook EW, et al. Neisseria gonorrhoeae Antimicrobial Resistance Among Men Who Have Sex With Men and Men Who Have Sex Exclusively With Women: The Gonococcal Isolate Surveillance Project, 2005-2010. Ann Intern Med 2013; 158:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/9\">",
"      Stall RD, Hays RB, Waldo CR, et al. The Gay '90s: a review of research in the 1990s on sexual behavior and HIV risk among men who have sex with men. AIDS 2000; 14 Suppl 3:S101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/10\">",
"      Kent CK, Chaw JK, Wong W, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005; 41:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/11\">",
"      Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/12\">",
"      Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997; 349:1868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/13\">",
"      Hook EW 3rd, Reichart CA, Upchurch DM, et al. Comparative behavioral epidemiology of gonococcal and chlamydial infections among patients attending a Baltimore, Maryland, sexually transmitted disease clinic. Am J Epidemiol 1992; 136:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/14\">",
"      Mertz KJ, Levine WC, Mosure DJ, et al. Screening women for gonorrhea: demographic screening criteria for general clinical use. Am J Public Health 1997; 87:1535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/15\">",
"      Klausner JD, Barrett DC, Dithmer D, et al. Risk factors for repeated gonococcal infections: San Francisco, 1990-1992. J Infect Dis 1998; 177:1766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/16\">",
"      Ellen JM, Hessol NA, Kohn RP, Bolan GA. An investigation of geographic clustering of repeat cases of gonorrhea and chlamydial infection in San Francisco, 1989-1993: evidence for core groups. J Infect Dis 1997; 175:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/17\">",
"      Platt R, Rice PA, McCormack WM. Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea. JAMA 1983; 250:3205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/18\">",
"      Lin JS, Donegan SP, Heeren TC, et al. Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partners. J Infect Dis 1998; 178:1707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/19\">",
"      Hook EW 3rd, Judson FN, Handsfield HH, et al. Auxotype/serovar diversity and antimicrobial resistance of Neisseria gonorrhoeae in two mid-sized American cities. Sex Transm Dis 1987; 14:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/20\">",
"      Kilmarx PH, Knapp JS, Xia M, et al. Intercity spread of gonococci with decreased susceptibility to fluoroquinolones: a unique focus in the United States. J Infect Dis 1998; 177:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/21\">",
"      O'Rourke M, Ison CA, Renton AM, Spratt BG. Opa-typing: a high-resolution tool for studying the epidemiology of gonorrhoea. Mol Microbiol 1995; 17:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/22\">",
"      Ward H, Ison CA, Day SE, et al. A prospective social and molecular investigation of gonococcal transmission. Lancet 2000; 356:1812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/23\">",
"      Heymans R, Schouls LM, van der Heide HG, et al. Multiple-locus variable-number tandem repeat analysis of Neisseria gonorrhoeae. J Clin Microbiol 2011; 49:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/24\">",
"      Heymans R, A Matser A, Bruisten SM, et al. Distinct Neisseria gonorrhoeae transmission networks among men who have sex with men in Amsterdam, The Netherlands. J Infect Dis 2012; 206:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/25\">",
"      Ross JD, Lewis DA. Cephalosporin resistant Neisseria gonorrhoeae: time to consider gentamicin? Sex Transm Infect 2012; 88:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/26\">",
"      Centers for Disease Control and Prevention (CDC). Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep 2007; 56:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/27\">",
"      Sparling PF. Antibiotic resistance in Neisseria gonorrhoeae. Med Clin North Am 1972; 56:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/28\">",
"      Alcorn TM, Cohen MS. Gonococcal pathogenesis: Adaptation and immune evasion in the human host. Curr Opin Infect Dis 1994; 7:310.",
"     </a>",
"    </li>",
"    <li>",
"     Elkins CE, Sparling PF. Immunobiology of Neisseria gonorrhoeae. In: Sexually Transmitted Diseases: Advances in Host Defense Mechanisms, Quinn TC, Gallin J, Fauci AS (Eds), Raven Press, New York 1992. Vol 8, p.113.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/30\">",
"      Seifert HS. Questions about gonococcal pilus phase- and antigenic variation. Mol Microbiol 1996; 21:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/31\">",
"      Scheuerpflug I, Rudel T, Ryll R, et al. Roles of PilC and PilE proteins in pilus-mediated adherence of Neisseria gonorrhoeae and Neisseria meningitidis to human erythrocytes and endothelial and epithelial cells. Infect Immun 1999; 67:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/32\">",
"      Rothbard JB, Fernandez R, Wang L, et al. Antibodies to peptides corresponding to a conserved sequence of gonococcal pilins block bacterial adhesion. Proc Natl Acad Sci U S A 1985; 82:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/33\">",
"      KELLOGG DS Jr, PEACOCK WL Jr, DEACON WE, et al. NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION. J Bacteriol 1963; 85:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/34\">",
"      Cohen MS, Sparling PF. Mucosal infection with Neisseria gonorrhoeae. Bacterial adaptation and mucosal defenses. J Clin Invest 1992; 89:1699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/35\">",
"      Virji M, Heckels JE. The role of common and type-specific pilus antigenic domains in adhesion and virulence of gonococci for human epithelial cells. J Gen Microbiol 1984; 130:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/36\">",
"      Rudel T, Boxberger HJ, Meyer TF. Pilus biogenesis and epithelial cell adherence of Neisseria gonorrhoeae pilC double knock-out mutants. Mol Microbiol 1995; 17:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/37\">",
"      Rudel T, Scheurerpflug I, Meyer TF. Neisseria PilC protein identified as type-4 pilus tip-located adhesin. Nature 1995; 373:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/38\">",
"      Swanson J, Barrera O, Sola J, Boslego J. Expression of outer membrane protein II by gonococci in experimental gonorrhea. J Exp Med 1988; 168:2121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/39\">",
"      Mayer LW. Rates in vitro changes of gonococcal colony opacity phenotypes. Infect Immun 1982; 37:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/40\">",
"      Weel JF, Hopman CT, van Putten JP. In situ expression and localization of Neisseria gonorrhoeae opacity proteins in infected epithelial cells: apparent role of Opa proteins in cellular invasion. J Exp Med 1991; 173:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/41\">",
"      Plummer FA, Chubb H, Simonsen JN, et al. Antibodies to opacity proteins (Opa) correlate with a reduced risk of gonococcal salpingitis. J Clin Invest 1994; 93:1748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/42\">",
"      Virji M, Watt SM, Barker S, et al. The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol Microbiol 1996; 22:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/43\">",
"      Bos MP, Grunert F, Belland RJ. Differential recognition of members of the carcinoembryonic antigen family by Opa variants of Neisseria gonorrhoeae. Infect Immun 1997; 65:2353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/44\">",
"      Dehio C, Freissler E, Lanz C, et al. Ligation of cell surface heparan sulfate proteoglycans by antibody-coated beads stimulates phagocytic uptake into epithelial cells: a model for cellular invasion by Neisseria gonorrhoeae. Exp Cell Res 1998; 242:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/45\">",
"      Grassm&eacute; H, Gulbins E, Brenner B, et al. Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell 1997; 91:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/46\">",
"      Layh-Schmitt G, Schmitt S, Buchanan TM. Interaction of non-piliated Neisseria gonorrhoeae strain 7122 and protein IA with an epithelial cell monolayer. Zentralbl Bakteriol 1989; 271:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/47\">",
"      van Putten JP, Duensing TD, Carlson J. Gonococcal invasion of epithelial cells driven by P.IA, a bacterial ion channel with GTP binding properties. J Exp Med 1998; 188:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/48\">",
"      Lynch EC, Blake MS, Gotschlich EC, Mauro A. Studies of Porins: Spontaneously Transferred from Whole Cells and Reconstituted from Purified Proteins of Neisseria gonorrhoeae and Neisseria meningitidis. Biophys J 1984; 45:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/49\">",
"      Young JD, Blake M, Mauro A, Cohn ZA. Properties of the major outer membrane protein from Neisseria gonorrhoeae incorporated into model lipid membranes. Proc Natl Acad Sci U S A 1983; 80:3831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/50\">",
"      McGee ZA, Johnson AP, Taylor-Robinson D. Pathogenic mechanisms of Neisseria gonorrhoeae: observations on damage to human fallopian tubes in organ culture by gonococci of colony type 1 or type 4. J Infect Dis 1981; 143:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/51\">",
"      McGee ZA, Stephens DS, Hoffman LH, et al. Mechanisms of mucosal invasion by pathogenic Neisseria. Rev Infect Dis 1983; 5 Suppl 4:S708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/52\">",
"      McGee ZA, Gorby GL, Wyrick PB, et al. Parasite-directed endocytosis. Rev Infect Dis 1988; 10 Suppl 2:S311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/53\">",
"      Brunham RC, Plummer F, Slaney L, et al. Correlation of auxotype and protein I type with expression of disease due to Neisseria gonorrhoeae. J Infect Dis 1985; 152:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/54\">",
"      Centers for Disease Control and Prevention (CDC). Fluoroquinolone-resistant Neisseria gonorrhoeae--San Diego, California, 1997. MMWR Morb Mortal Wkly Rep 1998; 47:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/55\">",
"      Apicella MA, Shero M, Jarvis GA, et al. Phenotypic variation in epitope expression of the Neisseria gonorrhoeae lipooligosaccharide. Infect Immun 1987; 55:1755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/56\">",
"      Stern A, Brown M, Nickel P, Meyer TF. Opacity genes in Neisseria gonorrhoeae: control of phase and antigenic variation. Cell 1986; 47:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/57\">",
"      Seifert HS, Wright CJ, Jerse AE, et al. Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J Clin Invest 1994; 93:2744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/58\">",
"      McQuillen DP, Gulati S, Ram S, et al. Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects. J Infect Dis 1999; 179:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/59\">",
"      Ram S, Sharma AK, Simpson SD, et al. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med 1998; 187:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/60\">",
"      Jarvis GA. Recognition and control of neisserial infection by antibody and complement. Trends Microbiol 1995; 3:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/61\">",
"      Rice PA. Molecular basis for serum resistance in Neisseria gonorrhoeae. Clin Microbiol Rev 1989; 2 Suppl:S112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/62\">",
"      Plummer FA, Chubb H, Simonsen JN, et al. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection. J Clin Invest 1993; 91:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/63\">",
"      Lammel CJ, Sweet RL, Rice PA, et al. Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. J Infect Dis 1985; 152:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/64\">",
"      Hobbs MM, Alcorn TM, Davis RH, et al. Molecular typing of Neisseria gonorrhoeae causing repeated infections: evolution of porin during passage within a community. J Infect Dis 1999; 179:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/65\">",
"      Sherrard J, Barlow D. Gonorrhoea in men: clinical and diagnostic aspects. Genitourin Med 1996; 72:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/66\">",
"      Stansfield VA. Diagnosis and management of anorectal gonorrhoea in women. Br J Vener Dis 1980; 56:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/67\">",
"      Klein EJ, Fisher LS, Chow AW, Guze LB. Anorectal gonococcal infection. Ann Intern Med 1977; 86:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/68\">",
"      Kolator B, Rodin P. Comparison of anal and rectal swabs in the diagnosis of anorectal gonorrhoea in women. Br J Vener Dis 1979; 55:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/69\">",
"      Kraus SJ. Incidence and therapy of gonococcal pharyngitis. Sex Transm Dis 1979; 6:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/70\">",
"      Osborne NG, Grubin L. Colonization of the pharynx with Neisseria gonorrhoeae: experience in a clinic for sexually transmitted diseases. Sex Transm Dis 1979; 6:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/71\">",
"      Hutt DM, Judson FN. Epidemiology and treatment of oropharyngeal gonorrhea. Ann Intern Med 1986; 104:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/72\">",
"      Komaroff AL, Aronson MD, Pass TM, Ervin CT. Prevalence of pharyngeal gonorrhea in general medical patients with sore throats. Sex Transm Dis 1980; 7:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/73\">",
"      McNeeley SG Jr. Gonococcal infections in women. Obstet Gynecol Clin North Am 1989; 16:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/74\">",
"      Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/75\">",
"      Korn AP, Hessol NA, Padian NS, et al. Risk factors for plasma cell endometritis among women with cervical Neisseria gonorrhoeae, cervical Chlamydia trachomatis, or bacterial vaginosis. Am J Obstet Gynecol 1998; 178:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/76\">",
"      Jossens MO, Eskenazi B, Schachter J, Sweet RL. Risk factors for pelvic inflammatory disease. A case control study. Sex Transm Dis 1996; 23:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/77\">",
"      W&oslash;lner-Hanssen P, Eschenbach DA, Paavonen J, et al. Association between vaginal douching and acute pelvic inflammatory disease. JAMA 1990; 263:1936.",
"     </a>",
"    </li>",
"    <li>",
"     Handsfield HH, Sparling PF. Neisseria gonorrhoeae. In: Principles and Practice of Infectious Diseases, 4th Ed., Mandell GL, Bennett JE, Dolin R.  (Eds), Churchill Livingstone, New York 1995. p.1909.",
"    </li>",
"    <li>",
"     file://www.cdc.gov/std/treatment/2010/default.htm (Accessed on February 11, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/80\">",
"      Geisler WM, Yu S, Hook EW 3rd. Chlamydial and gonococcal infection in men without polymorphonuclear leukocytes on gram stain: implications for diagnostic approach and management. Sex Transm Dis 2005; 32:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/81\">",
"      Holmes KK, Berger RE, Alexander ER. Acute epididymitis: etiology and therapy. Arch Androl 1979; 3:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/82\">",
"      Doble A, Taylor-Robinson D, Thomas BJ, et al. Acute epididymitis: a microbiological and ultrasonographic study. Br J Urol 1989; 63:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/83\">",
"      Hawkins DA, Taylor-Robinson D, Thomas BJ, Harris JR. Microbiological survey of acute epididymitis. Genitourin Med 1986; 62:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/84\">",
"      Craib KJ, Meddings DR, Strathdee SA, et al. Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men. Genitourin Med 1995; 71:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/85\">",
"      Schwarcz SK, Kellogg TA, McFarland W, et al. Characterization of sexually transmitted disease clinic patients with recent human immunodeficiency virus infection. J Infect Dis 2002; 186:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/86\">",
"      Klausner JD, Kohn R, Kent C. Etiology of clinical proctitis among men who have sex with men. Clin Infect Dis 2004; 38:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/87\">",
"      Morris SR, Klausner JD, Buchbinder SP, et al. Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis 2006; 43:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/20/38217/abstract/88\">",
"      Wiesner PJ, Tronca E, Bonin P, et al. Clinical spectrum of pharyngeal gonococcal infection. N Engl J Med 1973; 288:181.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7587 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-217.16.9.173-E29AE5AA73-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38217=[""].join("\n");
var outline_f37_20_38217=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21428802\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Trends in gonorrhea rates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Risk factors and attack rate for gonorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Molecular epidemiology of gonorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Epidemiology of antimicrobial resistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21428192\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21428214\">",
"      Attachment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21428221\">",
"      Local invasion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21428228\">",
"      Dissemination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21428235\">",
"      Adaptation to evade host immunity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5248334\">",
"      CLINICAL MANIFESTATIONS IN WOMEN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5248342\">",
"      Cervical infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5248350\">",
"      Urethritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5248357\">",
"      Anorectal infection and proctitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5248365\">",
"      Oropharyngeal infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5248373\">",
"      Other mucosal sites of infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5248381\">",
"      Pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5248641\">",
"      CLINICAL MANIFESTATIONS IN MEN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5248648\">",
"      Urethritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5248667\">",
"      Epididymitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5248686\">",
"      Proctitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5248693\">",
"      Pharyngitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21428802\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7587\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7587|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?16/10/16558\" title=\"figure 1\">",
"      Incidence of gonorrhea by age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?16/13/16598\" title=\"figure 2\">",
"      Rates of gonorrhea by state",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/26/4527\" title=\"figure 3\">",
"      Gonococcal membrane components",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7587|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/31/18929\" title=\"picture 1\">",
"      Gonorrhea and penile discharge",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=related_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/38/29286?source=related_link\">",
"      Cutaneous manifestations of gonorrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/35/26166?source=related_link\">",
"      Diagnosis of gonococcal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/56/3976?source=related_link\">",
"      Disseminated gonococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/20/44360?source=related_link\">",
"      Evaluation of the acute scrotum in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/18/18728?source=related_link\">",
"      Genital Chlamydia trachomatis infections in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/45/11992?source=related_link\">",
"      Pathogenesis of and risk factors for pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/44/1730?source=related_link\">",
"      Patient information: Gonorrhea (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/3/19514?source=related_link\">",
"      Treatment of uncomplicated gonococcal infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_20_38218="Nail lichen planus longitudinal fissuring";
var content_f37_20_38218=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85621%7EDERM%2F85620%7EDERM%2F85619&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85621%7EDERM%2F85620%7EDERM%2F85619&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Longitudinal nail fissuring caused by lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Trachyonychia induced by lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Lichen planus of the nails permanent nail dystrophy leading to pterigium and anonychia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Permanent nail dystrophy resulting in anonychia and pterigium (extension and adherence of the proximal nail fold to the nail bed secondary to scarring of the nail matrix).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38218=[""].join("\n");
var outline_f37_20_38218=null;
var title_f37_20_38219="Clinical manifestations subclinical hyperthyroidism";
var content_f37_20_38219=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F79602&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F79602&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical manifestations of subclinical hyperthyroidism",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Bone disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decreased bone density, especially in postmenopausal women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Biochemical markers of increased bone resorption",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Increased urinary pyridinoline and deoxypyridinoline excretion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Increased urinary hydroxyproline excretion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Heart disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased incidence of atrial fibrillation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased heart rate and incidence of atrial premature beats",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased cardiac contractility",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased left ventricular mass index and septal and posterior wall thickness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Laboratory abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decrease in serum total and LDL-cholesterol concentrations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased serum concentrations of hepatic enzymes and creatine kinase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased serum concentration of sex hormone-binding globulin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decreased time asleep at night",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Improved mood",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38219=[""].join("\n");
var outline_f37_20_38219=null;
var title_f37_20_38220="Conditions assoc second imm def";
var content_f37_20_38220=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F71244&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F71244&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Conditions associated with secondary immune deficiency",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Immunosuppressive therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cytotoxic chemotherapy for malignancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Treatment of autoimmune disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone marrow ablation prior to transplantation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Treatment or prophylaxis of graft vs. host disease following bone marrow transplantation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Treatment of rejection following solid organ transplantation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Microbial infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Viral infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        HIV, AIDS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Measles",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Herpes viruses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bacterial infection (superantigens)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mycobacterial infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parasitic infestation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Malignancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hodgkin's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic lymphocytic leukemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple myeloma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Solid tumors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Disorders of biochemical homeostasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diabetes mellitus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal insufficiency/dialysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatic insufficiency/cirrhosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Malnutrition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Autoimmune disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Systemic lupus erythematosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rheumatoid arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Burns",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Environmental exposure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Radiation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ionizing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ultraviolet",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Toxic chemicals",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stress",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asplenia/hyposplenism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allogeneic blood transfusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aging",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38220=[""].join("\n");
var outline_f37_20_38220=null;
var title_f37_20_38221="DRI infants";
var content_f37_20_38221=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62525%7EPEDS%2F78274&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62525%7EPEDS%2F78274&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Dietary reference intakes of selected nutrients for infants",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        0 to 6 months",
"       </td>",
"       <td class=\"subtitle1\">",
"        7 to 12 months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbohydrate",
"       </td>",
"       <td>",
"        60 g/day",
"       </td>",
"       <td>",
"        95 g/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fat",
"       </td>",
"       <td>",
"        31 g/day",
"       </td>",
"       <td>",
"        20 g/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Protein",
"       </td>",
"       <td>",
"        1.5 g/kg per day",
"       </td>",
"       <td>",
"        1 g/kg per day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calcium",
"       </td>",
"       <td>",
"        200 mg/day*",
"       </td>",
"       <td>",
"        260 mg/day*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iron",
"       </td>",
"       <td>",
"        0.27 mg/day",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        11 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zinc",
"       </td>",
"       <td>",
"        2 mg/day",
"       </td>",
"       <td>",
"        3 mg/day",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * These values represent the Adequate Intake for calcium; there was insufficient scientific data to calculate a recommended dietary allowance (RDA).",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     The iron stores of full-term infants whose birth weight was appropriate for gestational age meet their iron requirement until four to six months of age.",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br/>",
"     <ol>",
"      <li>",
"       Committee on Nutrition American Academy of Pediatrics. Appendix J. Dietary Reference Intakes: Recommended Intakes for Individuals, Food and Nutrition Board, Institute of Medicine. In: Pediatric Nutrition Handbook, 6th ed, Kleinman RE (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.1293.",
"      </li>",
"      <li>",
"       National Academies Press. Dietary Reference Intakes for Calcium and Vitamin D (2010). Available at file://books.nap.edu/openbook.php?record_id=13050&amp;page=291. Accessed on January 15, 2011.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Estimated energy requirements (low activity) and recommended dietary allowance (RDA) of selected nutrients for infants, children, and adolescents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Age",
"       </td>",
"       <td class=\"subtitle1\">",
"        Energy",
"        <br/>",
"        (kcal/day)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Protein",
"        <br/>",
"        (g/day)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Total",
"        <br/>",
"        (fat g/day)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Iron",
"        <br/>",
"        (mg/day)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Calcium",
"        <br/>",
"        (mg/day)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Zinc",
"        <br/>",
"        (mg/day)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        1-3 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Boys",
"       </td>",
"       <td>",
"        850-1300",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        30-40",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        700",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Girls",
"       </td>",
"       <td>",
"        750-1250",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        30-40",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        700",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        4-8 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Boys",
"       </td>",
"       <td>",
"        1400-1700",
"       </td>",
"       <td>",
"        19",
"       </td>",
"       <td>",
"        25-35",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Girls",
"       </td>",
"       <td>",
"        1300-1600",
"       </td>",
"       <td>",
"        19",
"       </td>",
"       <td>",
"        25-35",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        9-13 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Boys",
"       </td>",
"       <td>",
"        1800-2300",
"       </td>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        25-35",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        1300",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Girls",
"       </td>",
"       <td>",
"        1700-2000",
"       </td>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        25-35",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        1300",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        14-18 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Boys",
"       </td>",
"       <td>",
"        2500-2800",
"       </td>",
"       <td>",
"        52",
"       </td>",
"       <td>",
"        25-35",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        1300",
"       </td>",
"       <td>",
"        11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Girls",
"       </td>",
"       <td>",
"        2000",
"       </td>",
"       <td>",
"        46",
"       </td>",
"       <td>",
"        25-35",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        1300",
"       </td>",
"       <td>",
"        9",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from:",
"     <br>",
"      <ol>",
"       <li>",
"        The Dietary Reference Intakes, National Academy of Sciences, Washington, DC, 2002.",
"       </li>",
"       <li>",
"        National Academies Press. Dietary Reference Intakes for Calcium and Vitamin D (2010). Available at",
"        <a href=\"file://books.nap.edu/openbook.php?record_id=13050&amp;page=291\" target=\"_blank\">",
"         file://books.nap.edu/openbook.php?record_id=13050&amp;page=291",
"        </a>",
"        . Accessed on December 13, 2010.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38221=[""].join("\n");
var outline_f37_20_38221=null;
var title_f37_20_38222="TEE right pulmonary vessels";
var content_f37_20_38222=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F81803&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F81803&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left atrium, right pulmonary vein and artery on tranesophageal echocardiogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 287px; height: 191px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAC/AR8DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoqW2gmup0hto3lmc4VEGSfoK0LPQtRu3kWC0uZHj/1ixws5Q++OlAGVRW1beGtTu7/7Da2V3Ne8/wCjpAxfI/2RzWfqVhcabeS2l7FJBcxMVeKRSroR2IPQ0AVaKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKcqlmCqCWJwAOSTSAZOB1r2/4W+ELPw4ieIPFBj+0bQ1tak5K55BK45b0APFAHS/Bv4UnSo4da1qMtqDD93BwfJBHBPvjvXuMGk6Zp9lq91b+ZaXV3bATPbxkk7dxztHVuSMjk14zrvxktNLu1VPNaWJM+W0YAkPTrnI4we1cXN8bdRnkmAMySXKhSI3GxGB+UgY79CKAPTbP466Ba3N1Z6wl1Y3aXLGSRbIqxRXBVSCwIYjIOelfNfxI1+HxR451rWbRHS2u7hpIlcANt6DIHfvSeMfEt54guSL6O2EiSM7SrbIksjHj5mChm49TxXN0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFdr8IfD1l4n8bWWm6nHI9tMJPlRtpJWNm6/hXFV6h+zsxX4m6VgE588YH/XFqAPL6KKKACiiigAooooAKKKKACiiigAooooAKKKKAClALHABJ9BQBk4HWvfvgB8Mlu7231nXIwy7fMt4j0H+034dB7/AJAHI+AfB8dk/wDaviWOaBIQJEjKgEH6MME9OKwPGXia6vtSnKmRbVn3RwMSFUDI6Z4PP+ele0/HKztdFtLiyS1ik82YzxiMlWUkZ3e4Hpgj6da+aJg/nPvXD5JIHbvQAjSO5JdmYkYJJzTKKKAHsdwzzu7knrVrTf7Pzcf2mLojym8n7OV/1nbdn+H1xzVKn8sAFUfgOTQAyiiruqaXfaVNHFqVpNaySRrKiyoVLI3Rh7GgClXuHw08MaDdfBTUNd1DTdIudTTV57VWv5ZleSNbMSLFAI2AMpcZG7jG72rw+r0Or6lBYJYw6heR2UdwLtLdJmEazgYEoUHAfHG7rigD3j4c+FPBsXgCDUvFun6bFB/btzY3txqs8sE8cCRZCxqjDMobHGD3/B/ws+Fei+IPAd7LdWJl1DXXul0W5muBG1skSkRuU3DdvfKnAP3a8e8US60uj6b/AG1rd7dtqRbUjZzzvJsLfKszZJG9wG567dpzyKyF1zVlnsJl1S+E2nqEs3Fw+62AOQIzn5ACSeMVEJxqLmi9P8tAasUZY3hleKVGSRGKsrDBUjggimV3un+AtQ1nwlP4w1TXdMs7aaaQbr+aQzXEo+ZuinJJz1PNcGevrVgJRRRQAUVveDNI07XNbisNV1b+y45iEjmMDSguWAC4B469al+IPhoeEPF1/oYuxefZGVTME2BsqD0yfWgDnK9I+AbSD4kaUIFDv++4Izx5L15vXW/Cy9ew8a2M8ZUMgkIJ/wCubD+tAHJUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUV13w+8PR6vqyfawpVcOsDnb5wzjA/z2oA3/AIS+B21a/i1HUYHa1jcGOPH3jnqc8YHpX2N4dsVg+z+XCI3VNxU4Bz7f4VxnhbwXBYraXNtut1AGWGSCuM4xnpye1d+4ePzFClGVlPnBdwxjpj0PFAHiH7UcVl9jtLhrXfcZCpKZcbMckbPf1/Cvle8dHlyqhSODgcH3+tfYv7SGiwX+gLewqy3sSbFKAsHB6gL6jPWvjueMvO4XGRzyeTx0oA2vh5Z2+rfEHwvp+oQpNZ3WqWtvNHjaHR5lDAkYPIJFei6B8Oobz46a5YXekyx+GdMvL65MMhaJJLeGRgkauxHDExrnPRs5rx21uJ7K7hubSaW3uoHEkUsTFHjdTkMpHIIIyCK2tS8aeKdVtnt9T8S63eW7qUeK4v5ZFZSQSCGYgjKqcew9KAOn+PHhG28KeNUOlWotdH1O1ivrSISeYIgww8e7JztcN36EVwlvAzwM/kyMqHnbGSMHuTniludR1C+tLS0ury7ubazVltoZJWdIATlgik4UE9cVJptw8MEkawRnzWAErDlP/rUAVpV/e7oyyAjJLnBz3/yK6P4feDbrxpriafbzeSpUlp2QsqgYGTj6is67hk8pEWRpUhUhfkCgAndj1IPqa9z/AGaQLjXtxl8q3igbzY2PLngZXt3AoA8U8ZeE9Q8K63Ppt/EyzRE4JH317MPY0zwbpMGp6o0upFk0ixjN3fOpwfKXHyA/3nYqi+7CvtH41QeHZ/A9xFq9rbLdzofLupEybZscNuHzdew6+9fI3jGFfC2jxeGbeRXup3W91GVAQDwfJiGcHCod5z/FJg8rXNiZysqUH70vwXV/Lp5tFR7nM+INWn1zWrvUrsKJZ33bEGFRQMKijsqqAoHoBWdRWppdnDNpuq3Er4ktoFeJeMMxljUj3+V2P4VvCEYRUYqyRO57p4M0XTtb+B+lwazZ61c2EGpzNK+kxB5If3fDsCDlRnnpXIX3wdur6B77wRqFr4l00DePsrhLhAeMPCx3A5zXm9vrWp21rJbW9/cxW0n34kkKo31A4NR6fql5pzFrOYxMQVyFB4P1FUB3A+DXjluR4dvlX/bCj+ZFWbb4JeM5JFFxYRWkfV5Lm5iRUHqx3HH5Vw9z4i1W5t44JrxjGnIwihvxYDJ/E1Wj1O6jhaISKysQTvjVjx05IyP696APYvD/AMLdHbV4V0bxvo93q1hLHLNDIDHGQCCdkhO18dMY/KuW/aDMD/FnWpLa4huIpDGweKQOp/dr3H0rnIvGWrxTNKi6UGaMRHOk2hG32Hl4B9+tc/I7SOzvjceTgYoAZWr4Yu2stagmTOQGHHXlTWVUtvJ5UyvyMenXpQBFRRRQAUUUUAFFFFABRRRQAUUUUAFFFS24QyqZfuA89s+1AFjTrYSybpFYoBuAA6//AFq948EWlpc+TBYzw2NzEu5lvY0bYU6sVPzKCCOa8kht5orCHVGfy7ZpNitnI64APpxmuh8PyXL6r9phke9mKneQqOcDAPzODnA/hx70AfZGiSTPZJIrNLbn5R0kWVecYI/nWlaXSJMplhaIbTtAJPPpiuO+GeoT6loVqz3e6BDhRlVww4/h7f5xXZnT7iaynS9dVm5Ecw525zg80AReILC21jS57eaUIsyMrBTtye/I5FfA/j7Rl0jxNqNnHG0ccEjbAzhjt6jkAZH4CvvDRI5YbSGyMEsr7PnkIAAYdz9fYV4t+1N4Xu7xLHU4NPJMMRNxME5xnGOBz1zzQB8oLjcN2cd8UOQWJUYXsKvTWobLKCpB+Y4JqtcxeVtAfevOPagCOOMvnBAA6k9KdGzbiikfNgdSAadEhI37x1BIzjv3NTRxRyM05mVFRhkHJPXt60AakkjS5iiVJmRRExEfb09yOefavf8A9mfS7fzrzVHEUqQxrEI1G90Oc54yB+HP0r53iby1ZYWDo7jlQR09Dj6V9k/s4aBLp/gSS9nR0lvWaUB024GMLliMkcd/w7UbAeX+PfFa674t1jUNQgWHQtFfLwvIWF1cKSIYmAAwCcsR/dV8kmvBr26F/rEl3qrzzCebz7iRB+9bcSWIzwD168c17X8aNMmR0tkKR2NvcN57t8nnTNj5gOrBVwufZj3NeKXSpCzAATjvweD9K5MN+8bxD+1t/h6ffv8AcnsU9NChfxxJcubVJ0tXJMPnY3lM8Zxxn6V0vhrxElh4I8YaLJGh/tO3tvLfHzBo7mN8DnptL54PQehrmWM1wwDFjg4wei1p3+gXFlolvqcs1uYrhjGiJKpcbTg7kByBxxn0rrJMy3s7m5ilkt7aaWOIbpGjQsEHqSOlV6+jPgd4l0vT/CHhyIeILDR/7O1ue71iG4uRC1zbtAQpCnmUfw7Rk57d6+fdVkgm1O8ls08u1eZ2iTGNqFjtH5YoAZaWtxeSmO0glnkALFYkLHA6nA7UtrZXV2ZBa2005iUu/lxltg9TjoK9e/Z51+20yHXbC7u7bTI7mWzmbUTqcdlNEIpC5UbwTIhxhlUE+xzx3vhbxpoN9qOr3Hh/XLDQifG0WrXLXFwtp9r00JhgN2N+W3N5fX5ulAHy5TxG5jMgRvLBwWxwD6ZrX8aXVjf+Mdeu9JUJptxfzy2qhdoETSMUGO3ykcV6fDN9s/Zpm0y41fQFvItTW8t7P7ZbRXBt1Rg25AQ7PuJwGyxGMcYoA8elsrqG2iuJraeO3l/1crRkK/0PQ0XNnc2qxNdW00KyrujMiFQ49RnqK+qPiH4w8Lz+Dlhl1zTru1jutIeNLe6Wc38UQXzgbXk2m0biQMbtoHc1yfx18Raff+DdXt5NfsNZub3xKb/S0trpbhraz8nbg4J8oZwNhxyM470AfPdFFFABRRRQAUUUUAFFFFABRRT1RmGQDtHU46UAJtbbu2nb644q3ZrmKRo2wyjLBuh56D1NR3cUkWEKyCIfMpYEA571LdNK1nCsjRsqfdZVGeexYcnp3oA2Vul1a2jsm8uPyyWQS5jDeqgAgZz3610PhLSotV1xDZl7eSN96xYG4+yk8E9fSuNnluLzTraMkyQxEqq87tx745z07Vs+GEibVLeSK6SK5iIIhkQkHHck++PzoA+xfAE727y2y2rlfLDFjtUxsexXjB46jiu1s9RR1dJQ7beORnP6V498NvE3nTTtfaVLaiDkzK2Y+Rn75xkYJIHpXsi3MN9At0rxkxgFShDL9fxoAaDdNKsqSbLYMAEVOT61o/Z7W/tWtbtN4mUg7uPbGKzYbyS9jdZoVARcqwGAx9vpVP7Nex6X9q02VWmkcFo5srhe5B59KAPG/iF+z8s1xJdeGZkQEMXt5RkA9QFI5ya8F13wD4m0K88jVNGu4yOd6xlk/BgCK+8oLpl8mRsq23+9nB9xirVwUu1VbiGKZDnJKhufegD84bq1mtrmQSRiNn5CkYAH1NRzQNLDFBbmNVY5ZWcZz9T06190+MPhjoPiFGigtbW3uyGfzfJBDH/a6ZA5r5h8aaHB4Q1abSbd1uTBIFcy242AkcNk8EH1/lQBwuhaC19qMcCGOGRmUHLF1Ck/eJA4HHNfdfgea0t/Cenw2f2cwgAMsK7QxHX+tfN37PlhaeIPHWoC+gtJoRYtJJAiER8lVAAPHfPHpXtTzeHPC/izTNJguiryxMqaVHuk25Yt5nX5c5PXqAMcCvAxWa0p45ZVZ3krt9Latr57drPc1jTajznL/tCeFNR8QXkOoadvE9spAj4CbR3AxnPPf0r5y1vSNTtbzN1EEumX5gM7gcc4UdvwxzX6CSxQS2aTooySMlhk5P8AhVVtB0X7U9/c2lpPesu3zZUBYLnOPbmvfMj41+FHwk1fxfrNv9utLm00sMHlmdCoK8cDPXPavpTxv4N0G28Ef8I7a2cFvZ7P3jIoBwo/vHofc1ueJvFC22nPDor20LJIIiH4H0GPavDfHmu6lq95Pbm4kmV8LDbJG/zbT8znPRQcAZ6n2FAHifh2Kw8OfEi0fVUtZ9KMkkTPdwJcRR+ZGyLI8bAhghcPyP4elW9f8Xa/oGr3Om6p4f8ACUN3bttZf+EesiCOzKfLwVI5BHBBrY1C2nsNfsmjRDIUImlureJosNxtjSTKnG7g4znn3qbxBY3Ol6TDF4gsYfEnhuHEcNyk+y4scn/VxzgEAZJwrK6egBoA5D/hY2o/9AXwl/4Ttl/8brX8d+LbzTtcghsNN8MwQyabp9yUHh6wYb5bOGVzloSeXdjjPGcDisNtH8I3zZ07xHe2BPWHU9PZtnt5kJfcPfYv0rV8Waf4f1fVYLtfGuirFHYWVoVjtb5nLQ2sULEBrdRgmMkc9CKAMX/hPNX/AOfPw3/4Tmnf/GK6LR9YvLzwtrmseINP0EaUltLZ2vl6HZQPPdyoUQI8cStmMM0pIPBRe5AOHG/gnRxvVNU8R3Q6JMosbUH32s0jj6GM1j+JPEV/4hnha9aOO3t1MdtaW6COC2TOdsaDgD1PUnkknmgDGooooAKKKKACiiigAooooAKKKmtYWnmVFGe557UAS6dYTX9wkMC8s20E8DPYZ/Cr9zp08JktY/MWSJyJI1+bkcZBH+NbNqthHM0KRBEI3AKNzE5AIHPOMeufep9ZtY5bHzbWaRJyfLMIt/LIUDAJfv159PpQByl3GYVh3yyOhTaQGPBHVeRx9MUltPFA0f7syHdkgHB4PHPer8ljcXMdwdgVEwzkSbiWwB3JJ61jmFwcbD9R78D6UAdDFNY3shlEqabKrg5JLZPrj8KvR2btrXkXlwl6QuBLGpIdR0w3ByOnSsKOW5tpGguwy71w8Ui9e4PP1Nd54a8U6fqpig1PSLd5baMRpN9peL93juB3GD7UAeh/CX7TbX80b3LJYzIIDDIBJG+M5Zt3K5yOmOmTXtllMLe18tI4vsCIFws4RX6Y5PSvmLTrS1tLu2isZGbTbttkkkqZd8Z+6QCHHH/6ute7aL4elhvtNt7XWJEtwgliQygeaoHKkMDkcj6cUAd8GW2jSJplMM/KwknGAOeckn8OKvfak2EadabCE+cYypx+tcTrd5eQajJaXEqxRjDBCN4OO4AwMeta/hLWLGZ2VpbeVYciR4oioPtzx39aAOzRoLuIpauFnUAOAefoKjWOSR/OaMBAdq56/lVQXEP2gX0JlUyL8wIwVX0xgVOxSdRI7tGg+6Txg460APjuI4ZJDH5okfOGVM5P/wBavl39pXSry61CDUJHjIUeUDjDSH0AA5AxXvniLXLLS7GZru6RPkYJtbMjnONwH5Vzdr/Zt7IkOq3P9oLcJ5cKuBJgkDPGO9AHzJ8PfHc3gWy1trG3ZtYvY4oIZpACsCjdvYju33MDpwc+h5j+176fVJ9RuLt5L2Vt8k0kjb2Pc59f8ivU/i58MrjTdTFxo9pcDTycNuGAnc49Bj3P4VqeCvgXHq1sl5c6vb/ZmYY6Hjoc49/euenhKVOrOvGPvStd9dFZL0G5Nqx3PwQ+Ii6xo66bqF1K95EhzLIPkUdPvE8n8q0rf4iRw+JzpEEyXdnID5czDaAw5645713vh34aeHNH0uGCGyjmjRd2HUHe3XJ9TWRqXwxtdQvfMu1aOJOY4rYFFBzySQfmNdAjgfiNr8ttLHJG6XJQkQxRuAgY8FmCjLY4wO/fivMrq7vLyzluLCS7kmuX+a7kQISwxkHByFGDgYz0r6h0bwzp2mXJWwhUSBdnLcADvjoPr1q1B4IsLi3YX0SyeY7SHPIBY5PB9Sea8zAZnHHVKkacGowdrvS762XZaa+ZcocqV+p8s6X4UsddvhFcXEs12mB9mtEIVR0Ls7d8EZ44rufiBown0qy0ez3yWduFh+zxYPORgAY5PGSSa9li8AaPazXH2OLdNMvlnPRFrd0bwzpui24W3Tocl25P/wBb6CvTIPnyH4fad8P9F1LVP7C1jUhPbCB5IJ42mtwwO8xqV6cgZ5Ix+NfLGsCAapc/Y4pobYuTGkzBnVfRiAAT+Ar9Ktc1AaXZSTWcJubpvlijHAz7k18afFf4b6ncTap4qkurKJZHeaeN32BmPOI+PmJ9PWgDxOiiigAooooAKKKKACiiigAooooAUAsQB1NW7SYW8TOjBZXBUNu5H4fhVTtQBk4HWgDaRpnt3kkcxkdX5IBz3PvUy6u326OSV/PkRdsbKMY9856j1rI+1zeWInI2BgdpHA/ClE58xTEiBkPDIuN3saANee+aO/ln09pv3nzzCXbjPc8fzqvC1yZ1mEG1mfJAG7Ofr1/PNUp7tpmAkctjgFlwyfQj+VV4wWYRmRQmc/MTtoA6C9SwW98qOGZV2kBHAbY3THPOPpTv7LNpCJoWZo3kxGFlwTxz0+YdcZIxWIQiyBnQLEuMMnf8e/Tvit1dbYzW0EkUt1bcM0LTBw3TAyMkfQk49KAJtHF6l2yxvdRrHulaN3IZT3wMjJxnvXSeH9euIrWWVWmFrBKAZGZRKrHgNz746ZHrS6pM11NayWGn3Eenspi8iKZpk/3WDYwefXmqNlpkiW8moGxeWxL7WWNgkiNnpgZOOPegDv8ARPGN9fXs8uo6jC6oWSKeQAbDwTkDH8ute1+BrWfUoLaa7dLqNskthgyDJ2nGcenvXy/piwx62LmWW0jjVswpLcATZHqxGQPrgemcV9LeAPEU+qW1jPIERWOxlVixJ7HIA64NAHoWsmDSrLCl5Vf7qqFyT1xz+NY39v26JtlilbzRtKgriP3Y9h+dP8WvEthFbQSMWY5BcZC89ST/APWrxfxRrFzpEs0LamYoiuA8KbERu5KhWJ7fxD8KAO48Y6/p9xbJBYTpbSBS0k26NlIA5B3AgfjitH4WwWxvmvIktbiV0DecyrnZ6Lgf1xXh1iLvUZ4r2Rku9Pj3GOF1MQY9whAJOcE9c89q9R+HWlXE8zTWKCzLIN0O1lMfXgFjyOfSgD1nxJoy63p9xEkPksykCQKpx2OM15voXhXWNBMpW4kk0+IhUhVjtb8cccjt616XpV9PaRPbXZRZlUEMcBfr1/nTtOub2/hxdeUx35Xy3G3j3HBoAs6JeOYwJ0YZ4VRkhfart8/AVd5VfvkHgD3qcM+CuFBH93sO341BeJ5tqywsen3V5JPuawk3VfKtur/Rfq/lvs9jAnZreWX7KwhtzksV5LE+9TaJr8U941tNMqsFyFLDP4jtWBeXKhpYLyQqLb0YIAT0HpXLT63badYPJa7Y8Ehnb7xUHBJyDyfUk+tbJJaIR7RNPDBH5sjBQ2MHuaytS1EyApbg8EfMRx/9fivNPC/juPXFvIZ4JxIgBSSTc2cjoAR8nQ8f41rTastnALad9ryfJGSD0/E/KB6n0pgTazqcl1LKhUx2ifK8zlRvHcAcnJ4rzHx3cT63YyaPHKkG9fu5GIIBwS3ozAkAVr+INUEUi2emK95eSYMk+FEcCd9vT5iRj8fSuF1DVpfDH2y51FbeKGX5Y7eB1NxO/ZQcHIGeW7npQB5ro/gHw9qMPiCbUPFdno76fnyreZGLScdemSM8YUE+1eaTRPDIUkVlYdiCP51ua2Li5vr3UJy0YaQsF5YEk/d3dyO5+tZeq3t9qN4bnVbm4urpwMy3Dl3IAwMk89BQBTooooAKKKKACiipbaF7ieOGIAvIwVckAZPuelAEVFbniXw1e+Hjb/bZrGVZ1JQ21ykvTGQQDkde457ZrDoAKKU8HoR9aSgBSSxySSfU0qkj5lyMdxTaKAJEkKyBz8x9zT58FywjKK/ILZ/OoKdvbYE3NsznbnigC8vm2Vu+fs80My4IJDfjjqD70/RXMNy08RYFMcK3zdc/j07VVsLlrS5SeMKShBIZQwI9wa9avte8G6ppMMo0SSwmC/PdWMoRlbuCFHv3GKAOO13XYZbaNYYYI7pRtEkYdC3X74b5SeaxYtY1GJEPmyLEcqogIiGffaOfxpdbjsi8ktpqkt0S2NsqNuIHvWV5hEewBR/tY5/OgDrPDz3l9q1qJBbyzBwqRyFQT7HcOcele/8Ag2yWxvWt9Qt3slzmKW2hmMTk9iTwSMntj0r5Zs7jyLuOXn5D8pycr6Yr2X4b+M5X1OKLVJ7m4tlICyieTaB05Qdeo+uKAPpW+CxaQtuYftKKACwXax5xzyprnNcisEtGuJhF9oihZkgWUJHgjPzKOo+oPtXB/FfxsttZQHTWnQ/xSxwtFIvBxgMMHmvIL/xxfEpeWN2st0ATOxVvX0OAeCfWgDpNH1u2n1dyJFso4ZMhU8ySPOeVRVVh365Fev8Ag/xNY3OpQwK6xopByI5Ii7dCCGA/rXzHba3Ct+Ljy5fMP+s84hVdueygevrXX+ENV87UPMkVVSRwXQkpEAfcg4/DNAH2JYvZtcfaJox5MuNrbc/5/GuqtzGRtgiVNvA4HA9a8t0HVUXTbWSyt4haleVRw4f0C8j35I6V3Wha1FOjplQI+HOMDP15H6msZyc3yR+b/T1/IextuJQMwFcDghu5zzUCTsjsiKrSZ+bHJqRbzzFIRfmPCkHNZQeRLwfZ4tuAS0hGAfb1NaxioqyEcr4y0aWGO41G0g2zkhgH4Bb+9x39686vtSu7jTbi0vNO3vENzyCdVQnJ/PAwfc16v4jB1KyvIL1nECglyzKAw9MdcfWvnzxnb3NppE1jb36wWk4MQt5ECF+ucAcHt1zj8aYFjTfEOl+HI4Y4Zla7vGB+ywuZJWyR8zEgY79ccV6MgtNStkdhFLNH86xNkqpAxukPfGfpXz0thYaXp0UlqLn7ekZcqsxUjA/i2rn1wOKteEvEmpWFy1u8SySXLASO8ZyqDqxXsADwD9aAO21TXtV028aO08hoWztu5USMM2f4QTwuR16ntmuJ8UQTa5f2crzzaleEFQyt5cRI4/djrsHGWPJNdamvabquqJ5TWS2yY8y5u3XJOMjkkAng8DtzxWNquqww6vd6no2pefJt8gSMoxkHCrEgHIGc5PGaAOS8ZeFJ7LSo5b6eCJl+Ypub5ieiomOOvQn35rzzU7GfT5FjvT++xnyiTlQema6bUNWmt9YnvtaWW+vIyTEZpCURz0J9SPTP6Vymo3j31w00uWkY5Z2OWc+pNAHY+F/B+na54Sv9QuvEGi6dqCvmCG6vNjMoByCgU9eMHNcIRgkZBx3FJRQAUUUUAFFFFABRRRQBajiY2jTIjYU7S2Mg1W7VPZ3c9lN5ls+xsYPGQR9Kku5re4/eJCIZP4gp4b/CgCnRUscmzd3H9xuQabIVZsopUemc0AMopT7UlAFq0s5blXaBo9yclS4U/hmqxJY5JJPqaVRuYDIHuaHUoxU4yPQgj8xQA2lBOCATg9RSUUAFdd8PdSuLLWYGjg+17SNsLJvH1rka2vC0zxalHtuIIAT96VFYA/Q0Ad/8V/Gtxq1pFZXOkW1lMrB1IlEhx15XGBXlU0glbdtw5+8RgAn6AcV1Hjy4c3kURube4wvMkCqBj0+X61ynbFAFmymVZ1NwzeVkFsKGJ/Ou1tE0a7Rr4efaW9uqiSdrb5M9goLbS7YOBjsScAEjkdFspLu5Z1dIYYEMs0z/AHY0HGfckkAAckkCtLV/EC3UkUFtGRp0HEUT9T0y7erHHPTsBwBWM5OT5Ib9X2/4Pb732bXc99+Huvw39rAtl5Fn5I2qu/eyrn1IHJyCSOp9ABXqtpcWlyYg13CNvDgP1PvivlTwPqssOqxTwW928g+QGxhUlOxzkEeley6VrPiNCrTtbvu4aWQEsAR0YIQB6VpGKguVCPddHmja5WSCcPbY24IOAR6k8/lWjrE7CPeipKW9yB+eOK4Lwy2oz28E2oXls8WdzRxklUA54J5J+pNdZNdpfoiWCCSPvJtyAPbsaoCl9qXUbd4Ei81OQ+BhAenPr+VeUfEPRBLHLNLe2ytHnyjK3Ebcenpj3r0a4uf9P+xCK58rjey4JY9McdO3PFUfGmnx3WnNCkSMioRsZ8KM+uTgnrQB8qWt4LOeSJ7t5Yum/D4T/ax1Y46Dof1rC1LWLefFrYu4hf5nkz88hB43DAC+uMnHqa6bxMxsZ5INT0zT7p8sYh5jhgnGOOAB07A/XrXH6lDaPp4mkmRLydsLawoSFH1/L8+tAFnTdWhEptyIUiUHEmAXbPX5iCR1PQgfWrdzqlhpO/7Bdtc323iXcPLi/wB3HU8frXLYhsVZZSs8zDlFb5V+p7/hVGSRpXLSHLUAOuJ3nkZpJJHyScu2Tk9TUVFFABRRRQAUUUUAFFFFABRRRQAUUUUAOVgByqn65pfkKcFg/vyDTKKACiiigAooooAKKKKACraWrxwia4hdYjjaWVlDfQ4xVSvqrWPFui3fwsXRdN8SWv8AbH/CF2EP2S51BBZblJ81FXOFu1AHBOeU44NAHy9NBO0jfu5iVXeQwJIT1PHT3prWtwqI7QShHICMUOGz0x619Jar4i0My+I/E41/S5LHUfA50aC2W6U3X2tkRdjQffGCpyxGMc5ql43+Jul6V4C0XSNPvbnU7y78JafZm3iuUezsplJJkZQSRcKVHGARhc0AeDXVzcS2UWnw2rQw2wMkqKpLO/eRzjtnAHRR7liaDSZ2/KoI47n+dfQHxH8V+H5fBGoeKNG1CzfxP4ytLSyv7SFl8yz8sH7SSoOVEhSMcgZGSK+e6mMVFWQHQ6HeSCeNAYVcfdK7QB7kcA/jmu6sPGuoTXP2W+luPKJ2L5e3bjPcjA/EV5MrYIyAQDnGOtd3o+r2cumrDaQSw3iNuVsgqCDn69KoD3Dw/rLaDBa2CNPeLKMpCGZgBnJ3Hknr0Fex+DNYfUrTbGEjdVz5O3aVHTOD/wDW6V8l2XiTWb7WrZIJ/nhPLsokx2IwCQO3PBr1HQfHQsrkw3muW6cbpZblyq5/ugrj096APVfElrcI8sqRgzkHa4G5UPbAPGfpjrWRpMV1dWjSX13E1wCdoUKNo+mTz17/AJVwmu/HjRNNtHg0qF9QnVPkmKkJuz/Ezncfrg14Fr3xE8QajeXskd/Jbx3THfHEQBjPAB7Y9RigDvfjLPptnLchdTgur18AwxS7jGffB5/Hp6V4rPcSTMrO3K9KjkdpHLuxZmOST3ptABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQA7d8m3C/XHNKkjJ9zAPrimUUAPLkqVODnnOBn86WJkRsvGHHoSRUdFADnILEqoUHoB2pDSUUAFFFFABT4nMUiuuNynPIyKZRQBrDxFqyspivpoiv3fKOzb9MdKoXF1PczvNcTSSSudzuzElj6k+tQUUAKSWOSST6mkoqWGCSVZGjXIjXc3PQUARUUVc0vTrrVLr7PYRebNsZ9u4LwoyTkkdqAKdFaE2j30Oi2+rSQbdPuJGhil3qdzL1GM5H4is+gAorqNL8C67qdnb3VpbRmGe1mvIy0qjdHEcOevBz2rl6ACrumaXqGqytFpljc3kijcywRNIQPU4HFUq9a+CdxNbeHfGT280sUnk220xHBz5y9/oTQB/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The vertical (90&ordm;) imaging plane with very anterior rotation shows the left atrium (LA) and right upper pulmonary vein (RUPV). The right pulmonary artery may also be seen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Warren Manning, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38222=[""].join("\n");
var outline_f37_20_38222=null;
var title_f37_20_38223="Benign granuloma CT";
var content_f37_20_38223=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F58095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F58095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Benign granuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 361px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan confirms the location of the nodule in the lateral segment of the right middle lobe, abutting the major fissure and the parietal pleura. A small central lucency indicates incipient cavitation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_20_38223=[""].join("\n");
var outline_f37_20_38223=null;
